A Sterol-Regulatory Element Binding Protein Is Required for Cell Polarity, Hypoxia Adaptation, Azole Drug Resistance, and Virulence in Aspergillus fumigatus
Open accessAbstract
At the site of microbial infections, the significant influx of immune effector cells and the necrosis of tissue by the invading pathogen generate hypoxic microenvironments in which both the pathogen and host cells must survive. Currently, whether hypoxia adaptation is an important virulence attribute of opportunistic pathogenic molds is unknown. Here we report the characterization of a sterol-regulatory element binding protein, SrbA, in the opportunistic pathogenic mold, Aspergillus fumigatus. Loss of SrbA results in a mutant strain of the fungus that is incapable of growth in a hypoxic environment and consequently incapable of causing disease in two distinct murine models of invasive pulmonary aspergillosis (IPA). Transcriptional profiling revealed 87 genes that are affected by loss of SrbA function. Annotation of these genes implicated SrbA in maintaining sterol biosynthesis and hyphal morphology. Further examination of the SrbA null mutant consequently revealed that SrbA plays a critical role in ergosterol biosynthesis, resistance to the azole class of antifungal drugs, and in maintenance of cell polarity in A. fumigatus. Significantly, the SrbA null mutant was highly susceptible to fluconazole and voriconazole. Thus, these findings present a new function of SREBP proteins in filamentous fungi, and demonstrate for the first time that hypoxia adaptation is likely an important virulence attribute of pathogenic molds.
AI snapshot
Written from the paper’s full text.
TL;DR
The paper identifies SrbA, an SREBP homolog in *Aspergillus fumigatus*, as required for hypoxic growth, azole resistance, cell polarity, sterol biosynthesis, and virulence. Loss of SrbA renders the fungus avirulent in two murine models of invasive pulmonary aspergillosis and highly susceptible to fluconazole and voriconazole.
Key findings
- The ΔsrbA mutant SDW1 showed no detectable hyphal growth under hypoxia (1% O₂, 5% CO₂, 94% N₂), whereas wild-type CEA10 and reconstituted SDW2 grew normally; under normoxia, growth rates were comparable (P>0.01).
- SDW1 was highly susceptible to fluconazole (MIC 1 µg/ml) and voriconazole (MIC 0.012 µg/ml), while CEA10 and SDW2 were fluconazole-resistant and had voriconazole MICs of 0.125 µg/ml; all strains had equivalent MICs to amphotericin B (0.25 µg/ml) and caspofungin (0.125 µg/ml).
- Microarray profiling in hypoxia identified 87 SrbA-affected genes, including *srbA* itself (38.59-fold), NRPS1 (23.36-fold), ERG25 (15.79-fold), ERG3 (13.57-fold), and ERG24 (11.98-fold) higher in wild type than mutant. GC-MS showed a C-4 methylated sterol-to-ergosterol ratio of 1.94 in SDW1 versus no C-4 methylated sterol accumulation in wild type, suggesting an ERG25 block.
- SDW1 was avirulent in neutropenic CD1 mice (P=0.0002) and significantly attenuated in gp91phox−/− X-CGD mice (P=0.0054/0.005); no differences were found in oxidative stress resistance or RAW264.7 macrophage killing (P>0.01).
Methods
- A *srbA* null mutant (SDW1) was generated in *A. fumigatus* CEA17 by replacing an ~2.2-kb internal *srbA* coding fragment with *A. parasiticus pyrG*; a reconstituted strain (SDW2) was created, and strains were confirmed by Southern blot and PCR.
- Phenotypic assays included normoxic/hypoxic growth, microarray transcriptional profiling after 24 h hypoxia, E-test antifungal susceptibility, GC-MS sterol analysis, transmission electron microscopy, conidial germination, H₂O₂ sensitivity, and RAW264.7 macrophage killing.
- Virulence was tested in two murine IPA models: outbred CD1 neutropenic mice (n=12 per strain) and gp91phox−/− X-CGD mice (n=6 per strain), inoculated with 10⁶ conidia; survival was analyzed by log-rank tests, with microarray analysis by SAM using a 2-fold cutoff and zero false discovery rate.
Limitations
- The paper states that the mechanisms behind several phenotypes remain undefined, including how SrbA mediates hypoxia adaptation, azole resistance, and cell polarity; it also notes that no clear SCAP homolog was identified, that S1P/S2P protease mutants did not show expected hypoxic defects (unpublished data), and that SrbA regulation/activation was not elucidated.
- Evident from the text: transcriptional profiling was limited to one hypoxic condition and time point (24 h), so many of the 87 genes may be indirect effects; oxygen tension was not directly measured in infected tissue; and some supporting data are described as unpublished or not shown.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 46 cited sources checked · 0 supported · 0 flagged
- Findingcitation
Besides srbA itself, the gene with the highest fold difference in expression in SDW1 is a non-ribosomal peptide synthetase, AFUA_1g10380 (NRPS1 or pes1).
“Interestingly, besides srbA itself, the gene with the highest fold difference in expression in SDW1 is a non-ribosomal peptide synthetase, AFUA_1g10380 (NRPS1 or pes1) [43],[44].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [43] RA Cramer Jr, 2006, Phylogenomic analysis of non-ribosomal peptide synthetases in the genus <italic>Aspergillus</italic>., Gene source
Not checked in the free run.
- cites [44] EP Reeves, 2006, A nonribosomal peptide synthetase (Pes1) confers protection against oxidative stress in <italic>Aspergillus fumigatus</italic>., Febs J source
Not checked in the free run.
- Findingown data
No obvious defects in cell wall biosynthesis were observed in the mutant strain.
“However, no obvious defects in cell wall biosynthesis were observed in the mutant strain”
Quote in the paperNot a substantial claim - Findingown data
Several genes previously shown to be involved in ergosterol biosynthesis in fungi were transcriptionally repressed in the absence of SrbA, including ERG25, ERG24, and ERG3.
“Several genes previously shown to be involved in ergosterol biosynthesis in fungi were found to be transcriptionally repressed in the absence of SrbA including ERG25, ERG24, and ERG3 (Table 1).”
Quote in the paperSubstantial claim - Findingown data
After 96 hours of incubation in hypoxia, SDW1 continued to display undetectable growth.
“After 96 hours of incubation in hypoxia, SDW1 continued to display undetectable growth.”
Quote in the paperSubstantial claim - Findingown data
A significant number of genes involved in cell wall biosynthesis or homeostasis were repressed in SDW1 compared to wild type.
“In addition, a significant number of genes involved in cell wall biosynthesis or homeostasis were observed to be repressed in SDW1 compared to wild type.”
Quote in the paperNot a substantial claim
- Findingown data
SDW1 and SDW2 both displayed normal hyphal growth rates compared to the wild type strain CEA10 in normoxic conditions on glucose minimal medium (GMM).
“SDW1 and SDW2 both displayed normal hyphal growth rates compared to the wild type strain CEA10 in normoxic conditions on glucose minimal medium (GMM) (Figure 2A) (P>0.01).”
Quote in the paperSubstantial claim - Findingreasoning
The SrbA null mutant is incapable of causing disease in two distinct murine models of invasive pulmonary aspergillosis (IPA).
“consequently incapable of causing disease in two distinct murine models of invasive pulmonary aspergillosis (IPA)”
Quote in the paperSubstantial claim - Findingown data
AFUA_2g01260 (srbA) is induced 5.02 fold in response to hypoxia.
“only one, AFUA_2g01260 (induced 5.02 fold in response to hypoxia), had similarity with a functionally characterized protein, Sre1 from S. pombe [25]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [25] AL Hughes, 2005, SREBP pathway responds to sterols and functions as an oxygen sensor in fission yeast., Cell source
Not checked in the free run.
- Findingown data
The SrbA null mutant is highly susceptible to fluconazole and voriconazole.
“the SrbA null mutant was highly susceptible to fluconazole and voriconazole”
- Also stated in: § SrbA mediates resistance to the azole class of antifungal drugs · plain
“SDW1 growth was inhibited at the surprisingly low MIC of 1 µg/ml”
- Also stated in: § SrbA mediates resistance to the azole class of antifungal drugs · plain
“SDW1 was significantly more susceptible to Voriconazole and showed a MIC of only 0.012 µg/ml”
Quote in the paperSubstantial claim - Also stated in: § SrbA mediates resistance to the azole class of antifungal drugs · plain
- Findingown data
The overall set of genes putatively regulated by SrbA in A. fumigatus is significantly different from data obtained from Sre1 mutants in S. pombe and C. neoformans.
“However, the overall set of genes putatively regulated by SrbA in A. fumigatus is significantly different from data obtained from Sre1 mutants in the yeast S. pombe and C. neoformans.”
Quote in the paperSubstantial claim - Findingown data
Loss of SrbA results in a mutant strain of Aspergillus fumigatus that is incapable of growth in a hypoxic environment.
“Loss of SrbA results in a mutant strain of the fungus that is incapable of growth in a hypoxic environment”
- Also stated in: § SrbA is required for hypoxia adaptation in Aspergillus fumigatus · plain
“no hyphal growth of SDW1 was observed in hypoxic (1% O2, 5% CO2, 94% N2) conditions”
Quote in the paperSubstantial claim - Also stated in: § SrbA is required for hypoxia adaptation in Aspergillus fumigatus · plain
- Findingown data
Transcriptional profiling revealed 87 genes that are affected by loss of SrbA function.
“Transcriptional profiling revealed 87 genes that are affected by loss of SrbA function.”
- Also stated in: § Transcriptional profiling of SDW1 in response to hypoxia · hedged
“Microarray experiments comparing the transcriptional profiles of wild type strain CEA10 and SDW1 exposed to hypoxia for 24 hours revealed 87 significant genes possibly regulated by SrbA (Table 1).”
Quote in the paperSubstantial claim - Also stated in: § Transcriptional profiling of SDW1 in response to hypoxia · hedged
- Findingown data
We did not observe any increased susceptibility to oxidative stress in the SrbA null mutant.
“Interestingly, we did not observe any increased susceptibility to oxidative stress in the SrbA null mutant.”
Quote in the paperNot a substantial claim - Findingown data
Histopathological analyses confirmed the lack of fungal persistence and inflammation in mice infected with SDW1.
“Histopathological analyses of mice on days 14, 21 and 28 in this neutropenic model also confirmed the lack of fungal persistence and inflammation in mice infected with SDW1 (Figure 9).”
- Also stated in: § SrbA is required for fungal virulence in two distinct murine models · plain
“No sign of inflammation or fungal burden was observed in any surviving animal on day +14, +21 and +28 of the infection.”
Quote in the paperSubstantial claim - Also stated in: § SrbA is required for fungal virulence in two distinct murine models · plain
- Findingown data
Histopathological analysis of SDW1 infected survivors in the X-CGD model revealed persistence of granuloma like structures and fungal tissue.
“Histopathological analysis of SDW1 infected survivors in this model revealed persistence of granuloma like structures and fungal tissue (Figure 12).”
Quote in the paperSubstantial claim - Findingown data
After 28 days, SDW1 infected mice displayed no visible or microscopic signs of infection.
“After 28 days, SDW1 infected mice displayed no visible or microscopic signs of infection.”
Quote in the paperSubstantial claim - Findingown data
Lung homogenates from these animals revealed that the observed fungal tissue was still viable.
“Lung homogenates from these animals revealed that the observed fungal tissue was still viable.”
Quote in the paperSubstantial claim - Findingcitation
NRPS1 (or pes1) had the highest change in expression between wild type and the SrbA null mutant.
“For example, a non-ribosomal peptide synthetase, NRPS1 (or pes1), had the highest change in expression between wild type and the SrbA null mutant [43],[44].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [43] RA Cramer Jr, 2006, Phylogenomic analysis of non-ribosomal peptide synthetases in the genus <italic>Aspergillus</italic>., Gene source
Not checked in the free run.
- cites [44] EP Reeves, 2006, A nonribosomal peptide synthetase (Pes1) confers protection against oxidative stress in <italic>Aspergillus fumigatus</italic>., Febs J source
Not checked in the free run.
- Findingown data
After 48 hours, no detectable difference in growth morphology or colony diameter was observed among CEA10, SDW1, and SDW2 in the presence of 1 mM and 2.5 mM hydrogen peroxide on glucose minimal media.
“After 48 hours, we observed no detectable difference in growth morphology or colony diameter.”
Quote in the paperSubstantial claim - Findingown data
Semi-quantitative assessment of the percent of lung affected by infection at the early time point revealed no difference among strains (CEA10 = 1.3±0.5, SDW1 = 1.3±0.5, SDW2 = 1±0.0).
“Semi-quantitative assessment of the percent of the lung affected by the infection, measured by inflammation and necrosis, of mice infected with the 3 strains respectively revealed no difference at this early time point (CEA10 = 1.3±0.5, SDW1 = 1.3±0.5, SDW2 = 1±0.0).”
Quote in the paperNot a substantial claim - Findingown data
At days 14, 21, and 28, with the exception of one mouse, no fungal colonies were recoverable from lung homogenates of SDW1 infected mice.
“In particular, at days 14, 21, and 28 lung homogenates were taken from SDW1 infected mice and with the exception of one mouse, no fungal colonies were recoverable indicating that the mice had cleared the infection.”
Quote in the paperSubstantial claim - Findingcitation
Similar to C. neoformans and S. pombe, we observed SrbA dependent genes involved in ergosterol biosynthesis including ERG25, ERG24, and ERG3.
“Similar to C. neoformans and S. pombe, we observed SrbA dependent genes involved in ergosterol biosynthesis including ERG25, ERG24, and ERG3 [31]–[33].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [31]–[33]
Not checked in the free run.
- Findingown data
Semi-quantitative assessment at day 4 revealed significant differences in the percent of lung affected by infection among strains (CEA10 = 3.3±0.5, SDW1 = 2.3±0.5, SDW2 = 3.8±0.5).
“Semi-quantitative assessment of the inflammation and necrosis observed in the lungs of mice infected with the 3 strains respectively at this time point revealed significant differences in the percent of the lung affected by the infection (CEA10 = 3.3±0.5, SDW1 = 2.3±0.5, SDW2 = 3.8±0.5).”
Quote in the paperSubstantial claim - Findingown data
In the X-CGD murine model, mice infected with SDW1 had significant differences in survival compared with mice infected with wild type and reconstituted strains (P = 0.005).
“Similar to the neutropenic mouse model, X-CGD mice infected with strain SDW1 had significant differences in survival compared with mice infected with wild type and reconstituted strains (Figure 8B) (P = 0.005).”
Quote in the paperSubstantial claim - Findingown data
No clear cell wall defects were observed in SDW1.
“Confirming our suspicions that the mutant was not directly affected in cell wall biosynthesis we observed no clear cell wall defects.”
Quote in the paperNot a substantial claim - Findingown data
This phenotype was observed in over 80% of the SDW1 conidia examined.
“This phenotype was observed in over 80% of the SDW1 conidia examined.”
Quote in the paperNot a substantial claim - Findingown data
Similar cell wall-plasma membrane defects were observed in the SDW1 hyphae compared with the wild type hyphae.
“Similar cell wall-plasma membrane defects were observed in the SDW1 hyphae compared with the wild type hyphae (Figure 5D and 5E).”
Quote in the paperNot a substantial claim - Findingown data
An accumulation of electron dense objects was observed in the SDW1 hyphae.
“Importantly, an accumulation of electron dense objects was observed in the SDW1 hyphae.”
Quote in the paperSubstantial claim - Findingown data
CEA10 and SDW2 were susceptible to Voriconazole with MIC of 0.125 μg/ml.
“On the plates with Voriconazole we could observe that CEA10 and SDW2 were susceptible as expected (MIC of 0.125 µg/ml respectively).”
Quote in the paperSubstantial claim - Findingown data
A significant difference in mortality was observed between mice infected with SDW1 and mice infected with either SDW2 or CEA10 (P = 0.0002).
“Consequently, a significant difference in mortality was observed between the mice infected with SDW1 and mice infected with either SDW2 or CEA1O (P = 0.0002).”
Quote in the paperSubstantial claim - Findingown data
A significant defect in the cell wall-plasma membrane interface occurs in the absence of SrbA.
“A striking phenotype was consequently observed in conidia from SDW1 that suggested a significant defect in the cell wall-plasma membrane interface occurs in the absence of SrbA (Figure 5A and 5B).”
Quote in the paperSubstantial claim - Findingown data
The size and density of the mutant conidia were comparable to the wild type strain as measured by flow cytometry.
“However, the size and density of the mutant conidia were comparable to the wild type strain as measured by flow cytometry (data not shown).”
Quote in the paperNot a substantial claim - Findingown data
In the first murine model, outbred CD1 neutropenic mice infected with SDW1 displayed no symptoms associated with IPA.
“In the first model, outbred CD1 neutropenic mice infected with SDW1 displayed no symptoms associated with IPA (Figure 8A).”
Quote in the paperSubstantial claim - Findingown data
A general thickening of the intracellular space between the cell wall and plasma membrane is observed in SDW1 conidia and hyphae compared with the wild type.
“However, a general thickening of the intracellular space between the cell wall and plasma membrane is observed in SDW1 conidia and hyphae compared with the wild type (Figure 5A and 5B and 5D and 5E).”
Quote in the paperNot a substantial claim - Findingown data
Only one mouse infected with SDW1 succumbed to the infection in the X-CGD model.
“However, only one mouse infected with SDW1 succumbed to the infection.”
Quote in the paperNot a substantial claim - Findingcitation
Unlike C. neoformans, we did not observe SrbA dependent genes involved in iron or copper uptake in A. fumigatus.
“Unlike C. neoformans, we did not observe SrbA dependent genes involved in iron or copper uptake in A. fumigatus [32].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [32] YC Chang, 2007, Sre1p, a regulator of oxygen sensing and sterol homeostasis, is required for virulence in <italic>Cryptococcus neoformans</italic>., Mol Microbiol source
Not checked in the free run.
- Findingown data
No significant difference in conidia killing was observed between CEA10, SDW1, and SDW2 (P>0.01).
“As presented in figure 13, no significant difference in conidia killing was observed between CEA10, SDW1, and SDW2 (P>0.01).”
Quote in the paperSubstantial claim - Findingown data
The cell wall-plasma membrane defect is apparently exacerbated by the electron beam, which causes separation between the cell wall and plasma membrane in SDW1 conidia.
“This defect is apparently exacerbated by the electron beam, which causes a separation between the cell wall and plasma membrane in SDW1 conidia (Figure 5C).”
Quote in the paperNot a substantial claim - Findingown data
Unlike the neutropenic mouse model, X-CGD mice all displayed symptoms of IPA during the preliminary stages of infection.
“Unlike the neutropenic mouse model, these mice all displayed symptoms of IPA during the preliminary stages of infection.”
Quote in the paperNot a substantial claim - Findingown data
In the first murine model, the SDW1 strain was completely avirulent.
“Indeed, in this murine model, the SDW1 strain was completely avirulent (Figure 8A).”
Quote in the paperSubstantial claim - Findingown data
Mice infected with wild type CEA10 and reconstituted strain SDW2 displayed symptoms of A. fumigatus infection including hunched posture, ruffled fur, weight loss, and increased respiration.
“This was in contrast to mice infected with the wild type CEA10 and reconstituted strain SDW2 that displayed well described symptoms of A. fumigatus infection including hunched posture, ruffled fur, weight loss, and increased respiration.”
Quote in the paperSubstantial claim - Findingown data
On day 1 of infection, fungal germination and growth is observed in mice infected with all 3 strains of the fungus.
“On day 1 of the infection, fungal germination and growth is observed in mice infected respectively with all 3 strains of the fungus.”
- Also stated in: § SrbA is required for fungal virulence in two distinct murine models · plain
“GMS staining revealed that fungal colonization and germination is observed in all infected animals but not the mock control.”
Quote in the paperNot a substantial claim - Also stated in: § SrbA is required for fungal virulence in two distinct murine models · plain
- Findingown data
GC-MS profiles demonstrated a significant accumulation of 4-methyl sterols in the SrbA null mutant SDW1 that was not observed in the wild type strain CEA10.
“The GC-MS profiles demonstrated a significant accumulation of 4-methyl sterols in the SrbA null mutant, SDW1, that was not observed in the wild type strain CEA10 (Figure 7).”
Quote in the paperSubstantial claim - Findingown data
In a repeat experiment, 3 additional X-CGD mice infected with SDW1 succumbed on day 4 to the infection.
“In a repeat experiment, 3 additional X-CGD mice infected with SDW1 also succumbed on day 4 to the infection.”
Quote in the paperNot a substantial claim - Findingown data
SDW1 has a significant defect in hyphal tip branching that is not apparent in strains CEA10 and SDW2.
“We observed a significant defect in hyphal tip branching in SDW1 that is not apparent in strains CEA10 and SDW2 (Figure 4).”
Quote in the paperSubstantial claim - Findingown data
Viability, as measured by conidia germination, was not significantly different between the wild type, SDW1 and SDW2 strains.
“These experiments revealed that viability, as measured by conidia germination, was not significantly different between the wild type, SDW1 and SDW2 strains (Figure 6) (P>0.01).”
Quote in the paperNot a substantial claim - Findingown data
Visual inspection of SDW1 colony morphology in standard laboratory conditions did not reveal any apparent morphological phenotypes.
“Visual inspection of SDW1 colony morphology in standard laboratory conditions did not reveal any apparent morphological phenotypes (Figure 2B).”
Quote in the paperNot a substantial claim - Findingown data
Unlike C. neoformans and S. pombe, we did not observe any genes with an annotation that would clearly point to a role in allowing Aspergillus to adapt to hypoxia.
“Overall, however, unlike C. neoformans and S. pombe, we did not observe any genes with an annotation that would clearly point to a role in allowing Aspergillus to adapt to hypoxia.”
Quote in the paperNot a substantial claim - Findingown data
The SrbA mutant did not display increased sensitivity to hydrogen peroxide.
“In addition, the SrbA mutant did not display increased sensitivity to hydrogen peroxide.”
Quote in the paperSubstantial claim - Findingown data
By day 14 of the infection, little evidence of inflammation or fungal burden was evident in mice infected with the SrbA null mutant.
“Indeed, by day 14 of the infection, little evidence of inflammation or fungal burden was evident in mice infected with the SrbA null mutant.”
Quote in the paperSubstantial claim - Findingcitation
Loss of SrbA resulted in a strain of A. fumigatus highly susceptible to fluconazole, an azole that normally has minimal activity against A. fumigatus.
“Interestingly, loss of SrbA resulted in a strain of A. fumigatus highly susceptible to fluconazole, an azole that normally has minimal activity against A. fumigatus [58],[59].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [58] F Sabatelli, 2006, In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts., Antimicrob Agents Chemother source
Not checked in the free run.
- cites [59] TC White, 1998, Clinical, cellular, and molecular factors that contribute to antifungal drug resistance., Clin Microbiol Rev source
Not checked in the free run.
- Findingown data
The SrbA null mutant conidia showed no difference in susceptibility to macrophage (RAW264.7 cells) killing compared with the wild type strain.
“Furthermore, we also have examined the susceptibility of the SrbA null mutant conidia to macrophage (RAW264.7 cells) killing and found no difference with the wild type strain.”
Quote in the paperSubstantial claim - Findingown data
Histopathological findings with the SrbA mutant strain revealed fungal growth in the neutropenic model early in the infection.
“Our histopathological findings with the SrbA mutant strain revealed fungal growth in this model early in the infection.”
Quote in the paperSubstantial claim - Findingown data
We identified SrbA in a transcriptional profiling screen of A. fumigatus in response to hypoxia (induced >5 fold).
“First, we identified SrbA in a transcriptional profiling screen of A. fumigatus in response to hypoxia (induced >5 fold).”
Quote in the paperSubstantial claim - Findingown data
In vitro experiments revealed that the growth defect of the SrbA mutant in hypoxia was not fungicidal but fungistatic.
“Furthermore, our in vitro experiments revealed that the growth defect of the SrbA mutant in hypoxia was not fungicidal but fungistatic.”
Quote in the paperSubstantial claim - Findingown data
Unlike the neutropenic mice, we could detect persistence of viable SDW1 in the lungs of surviving X-CGD mice out to day 14.
“Furthermore, unlike the neutropenic mice, we could detect the persistence of viable SDW1 in the lungs of these surviving mice out to day 14.”
Quote in the paperNot a substantial claim - Findingown data
Despite extensive bioinformatic analyses, we were unable to identify a clear homolog of the sterol cleavage activating protein (SCAP).
“First, despite extensive bioinformatic analyses, we were unable to identify a clear homolog of the sterol cleavage activating protein (SCAP).”
Quote in the paperSubstantial claim - Findingown data
By day 14, we were unable to recover viable colonies from mice infected with the SrbA null mutant strain.
“However, by day 14, we were unable to recover viable colonies from mice infected with the SrbA null mutant strain.”
Quote in the paperSubstantial claim - Findingown data
The A. fumigatus SrbA null mutant produced substantial levels of ergosterol even in the absence of SrbA.
“We observed that the A. fumigatus SrbA null mutant produced substantial levels of ergosterol even in the absence of SrbA.”
Quote in the paperSubstantial claim - Findingown data
Generation of null mutants in putative site-1 (S1P) and site-2 (S2P) protease homologs in A. fumigatus did not demonstrate expected defects in hypoxic growth.
“Third, though sequence identity was extremely low, generation of null mutants in putative site-1 (S1P) and site-2 (S2P) protease homologs in A. fumigatus did not demonstrate expected defects in hypoxic growth (Willger and Cramer, unpublished data).”
Quote in the paperNot a substantial claim - Findingown data
We could identify a clear Insig1 homolog, which we have named InsA.
“We could, however, identify a clear Insig1 homolog, which we have named InsA.”
Quote in the paperNot a substantial claim - Findingown data
Transcriptional profiling of the SrbA mutant revealed numerous transporters possibly regulated by SrbA.
“Transcriptional profiling of the SrbA mutant revealed numerous transporters possibly regulated by SrbA.”
Quote in the paperNot a substantial claim - Findingown data
Exogenous addition of ergosterol or lanosterol did not alter growth of the wild type strain in hypoxia.
“Nor did exogenous addition of these sterols alter growth of the wild type strain in hypoxia as is the case for S. cerevisiae, which requires exogenous sterols for anaerobic growth.”
Quote in the paperSubstantial claim - Findingcitation
Unlike the neutropenic mouse model, extensive signs of chronic inflammation remained evident in the X-CGD mice post-day 14.
“Unlike the neutropenic mouse model, extensive signs of chronic inflammation remained evident in the X-CGD mice post-day 14, consistent with previously reported results in these animals [45].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] DE Morgenstern, 1997, Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to <italic>Aspergillus fumigatus</italic>., J Exp Med source
Not checked in the free run.
- Findingnone given
In the neutropenic mouse model, significant inflammation and tissue necrosis is observed in histopathological examinations.
“In this model, significant inflammation and tissue necrosis is observed in histopathological examinations.”
Quote in the paperSubstantial claim - Findingown data
We could not rescue the SrbA phenotype in hypoxia with addition of ergosterol or lanosterol.
“We could not rescue the SrbA phenotype in hypoxia with addition of ergosterol or lanosterol (data not shown).”
Quote in the paperSubstantial claim - Interpretationown data
Hypoxia adaptation is likely an important virulence attribute of pathogenic molds.
“demonstrate for the first time that hypoxia adaptation is likely an important virulence attribute of pathogenic molds”
Quote in the paperSubstantial claim - Study design and conductown data
Ectopic re-introduction of the wild type srbA allele into SDW1 (resulting in strain SDW2) allowed attribution of all resulting phenotypes specifically to the absence of srbA in SDW1.
“Ectopic re-introduction of the wild type srbA allele into SDW1 (resulting in strain SDW2) allowed us to attribute all resulting phenotypes specifically to the absence of srbA in SDW1.”
Quote in the paperSubstantial claim - Interpretationown data
SrbA in A. fumigatus is involved in mediating the hypoxic response by an undefined mechanism.
“and that SrbA in A. fumigatus is involved in mediating this response by an undefined mechanism”
Quote in the paperSubstantial claim - Interpretationreasoning
Invasive fungal pathogens like A. fumigatus are likely subjected to hypoxia during fungal pathogenesis.
“it follows that invasive fungal pathogens like A. fumigatus are likely subjected to hypoxia during fungal pathogenesis”
Quote in the paperSubstantial claim - Interpretationreasoning
The transcriptional profiling results are likely indirect effects of the altered cell polarity of the mutant.
“and thus the transcriptional profiling results are likely indirect effects of the altered cell polarity of the mutant (discussed below)”
Quote in the paperNot a substantial claim - Interpretationown data
SrbA plays a critical role in ergosterol biosynthesis in A. fumigatus.
“SrbA plays a critical role in ergosterol biosynthesis”
- Also stated in: § Transcriptional profiling of SDW1 in response to hypoxia · plain
“Several genes previously shown to be involved in ergosterol biosynthesis in fungi were found to be transcriptionally repressed in the absence of SrbA including ERG25, ERG24, and ERG3 (Table 1).”
Quote in the paperSubstantial claim - Also stated in: § Transcriptional profiling of SDW1 in response to hypoxia · plain
- Interpretationown data
The lack of effect of Caspofungin provides support for the hypothesis that the mutant is likely not directly affected in cell wall biosynthesis.
“The lack of effect of Caspofungin provides support for our hypothesis that the mutant is likely not directly affected in cell wall biosynthesis as possibly suggested by the transcriptional profiling data.”
Quote in the paperSubstantial claim - Interpretationreasoning
Pathogenic molds such as A. fumigatus must possess mechanisms to adapt to hypoxic microenvironments found in vivo during infection.
“Consequently, it seems probable that pathogenic molds such as A. fumigatus must possess mechanisms to adapt to hypoxic microenvironments found in vivo during infection.”
Quote in the paperSubstantial claim - Interpretationown data
SrbA plays a distinct role in filamentous fungal biology.
“Consequently, these results strongly suggest that SrbA plays a distinct role in filamentous fungal biology.”
Quote in the paperSubstantial claim - Interpretationcitation
There is an important link between sterol biosynthesis, hypoxia adaptation, azole drug resistance, and the virulence of pathogenic yeasts.
“Taken together, these observations demonstrate an important link between sterol biosynthesis, hypoxia adaptation, azole drug resistance, and the virulence of pathogenic yeasts.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [32] YC Chang, 2007, Sre1p, a regulator of oxygen sensing and sterol homeostasis, is required for virulence in <italic>Cryptococcus neoformans</italic>., Mol Microbiol source
Not checked in the free run.
- cites [33] CD Chun, 2007, A Link between virulence and homeostatic responses to hypoxia during infection by the human fungal pathogen <italic>Cryptococcus neoformans</italic>., PLoS Pathog source
Not checked in the free run.
- Interpretationown data
A. fumigatus can rapidly adapt to hypoxic microenvironments.
“These results indicate that A. fumigatus can rapidly adapt to hypoxic microenvironments”
Quote in the paperSubstantial claim - Interpretationown data
These findings present a new function of SREBP proteins in filamentous fungi.
“Thus, these findings present a new function of SREBP proteins in filamentous fungi”
Quote in the paperSubstantial claim - Interpretationown data
SrbA plays a critical role in resistance to the azole class of antifungal drugs.
“resistance to the azole class of antifungal drugs”
- Also stated in: § SrbA mediates resistance to the azole class of antifungal drugs · plain
“we found that SrbA is required for resistance to Fluconazole and Voriconazole, but not Amphotericin B or Caspofungin”
Quote in the paperSubstantial claim - Also stated in: § SrbA mediates resistance to the azole class of antifungal drugs · plain
- Interpretationreasoning
AFUA_2g01260 is likely the SREBP homolog in A. fumigatus, named srbA.
“Consequently, these results suggest that AFUA_2g01260 is likely the SREBP homolog in A. fumigatus, and we consequently named this gene srbA”
Quote in the paperSubstantial claim - Premisecitation
Sites of inflammation contain significantly low levels of oxygen (hypoxia).
“it is well established that sites of inflammation contain significantly low levels of oxygen (hypoxia) [5]–[7]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [5]–[7]
Not checked in the free run.
- Interpretationown data
SrbA plays a critical role in maintenance of cell polarity in A. fumigatus.
“maintenance of cell polarity in A. fumigatus”
Quote in the paperSubstantial claim - Interpretationown data
Mechanisms of hypoxia adaptation are almost certainly different in molds than yeast.
“This result further illustrates that mechanisms of hypoxia adaptation are almost certainly different in molds than yeast.”
Quote in the paperNot a substantial claim - Interpretationown data
Despite normal growth rates in vitro in normoxic conditions, the SDW1 strain is severely attenuated in its ability to cause lethal disease in two distinct murine models of IPA.
“These results indicate that despite normal growth rates in vitro in normoxic conditions, the SDW1 strain is severely attenuated in its ability to cause lethal disease in two distinct murine models of IPA.”
- Also stated in: § SrbA is required for fungal virulence in two distinct murine models · plain
“SDW1 is significantly less virulent than the wild type CEA10 and the reconstituted strain SDW2 in both murine models.”
Quote in the paperSubstantial claim - Also stated in: § SrbA is required for fungal virulence in two distinct murine models · plain
- Interpretationown data
Increased susceptibility to oxidative stress and macrophage killing is not responsible for the virulence defect observed in the absence of SrbA.
“We conclude that increased susceptibility to oxidative stress and macrophage killing is not responsible for the virulence defect observed in the absence of SrbA.”
- Also stated in: § SrbA is not required for oxidative stress resistance and resistance to macrophage killing · plain
“Loss of SrbA does not affect susceptibility to conidia killing by RAW264.7 cells.”
Quote in the paperSubstantial claim - Also stated in: § SrbA is not required for oxidative stress resistance and resistance to macrophage killing · plain
- Interpretationown data
Mice infected with SDW1 had cleared the infection.
“In particular, at days 14, 21, and 28 lung homogenates were taken from SDW1 infected mice and with the exception of one mouse, no fungal colonies were recoverable indicating that the mice had cleared the infection.”
- Also stated in: § SrbA is required for fungal virulence in two distinct murine models · hedged
“This result indicates that in this murine model, the immune system is capable of clearing the fungal infection in the absence of SrbA.”
Quote in the paperSubstantial claim - Also stated in: § SrbA is required for fungal virulence in two distinct murine models · hedged
- Interpretationown data
SrbA is involved in maintaining cell polarity that directs hyphal growth.
“This phenotype suggests that SrbA is involved in maintaining cell polarity that directs hyphal growth.”
Quote in the paperSubstantial claim - Interpretationown data
SDW1 conidia are viable in vivo during the early stages of infection.
“This observation confirms the viability of SDW1 conidia in vivo (Figure 10).”
- Also stated in: § SrbA is required for fungal virulence in two distinct murine models · hedged
“This result indicates that SDW1 conidia are viable in vivo during the early stages of infection.”
Quote in the paperSubstantial claim - Also stated in: § SrbA is required for fungal virulence in two distinct murine models · hedged
- Interpretationown data
Abnormal conidial and hyphal morphology in SDW1 suggested possible alterations in sterol content in the absence of SrbA.
“In addition, the abnormal conidial and hyphal morphology observed via light microscopy and TEM micrographs in SDW1 also suggested possible alterations in sterol content in the absence of SrbA.”
Quote in the paperNot a substantial claim - Interpretationown data
Regulation of ergosterol biosynthesis is a conserved function of SREBPs in fungi.
“This result suggests that regulation of ergosterol biosynthesis is a conserved function of SREBPs in fungi.”
Quote in the paperNot a substantial claim - Interpretationown data
These results suggest that ergosterol can still be synthesized in the absence of SrbA in A. fumigatus.
“In addition, these results suggest that ergosterol can still be synthesized in the absence of SrbA in A. fumigatus.”
Quote in the paperSubstantial claim - Interpretationown data
This data is consistent with the observed in vitro phenotype of the SDW1 strain in hypoxia.
“This data is consistent with the observed in vitro phenotype of the SDW1 strain in hypoxia.”
Quote in the paperNot a substantial claim - Premisecitation
In the yeasts S. pombe and C. neoformans, SREBP homologs are crucial for sterol biosynthesis, survival under hypoxic conditions, resistance to azole antifungal agents, and fungal virulence.
“In the yeasts S. pombe and C. neoformans, SREBP homologs are crucial for sterol biosynthesis, survival under hypoxic conditions, resistance to azole antifungal agents, and fungal virulence [25],[32],[33].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [25] AL Hughes, 2005, SREBP pathway responds to sterols and functions as an oxygen sensor in fission yeast., Cell source
Not checked in the free run.
- cites [32] YC Chang, 2007, Sre1p, a regulator of oxygen sensing and sterol homeostasis, is required for virulence in <italic>Cryptococcus neoformans</italic>., Mol Microbiol source
Not checked in the free run.
- cites [33] CD Chun, 2007, A Link between virulence and homeostatic responses to hypoxia during infection by the human fungal pathogen <italic>Cryptococcus neoformans</italic>., PLoS Pathog source
Not checked in the free run.
- Interpretationown data
Transcriptional profiling data suggests transcriptional regulation of ERG25 by SrbA in A. fumigatus.
“These alterations are supported by the transcriptional profiling data, which suggests transcriptional regulation of ERG25 by SrbA in A. fumigatus (Table 1).”
Quote in the paperNot a substantial claim - Interpretationown data
SrbA is critical for maintaining the cell wall - plasma membrane interface.
“These results suggest that SrbA is critical for maintaining the cell wall – plasma membrane interface”
Quote in the paperSubstantial claim - Interpretationown data
SrbA mediates resistance to the azole class of antifungal drugs by an undefined mechanism.
“These clinically significant results suggest that SrbA mediates resistance to the azole class of antifungal drugs by an undefined mechanism.”
Quote in the paperSubstantial claim - Interpretationown data
Our results suggest additional functions of SREBPs in filamentous fungi, most importantly a role in maintenance of cell polarity.
“However, our results suggest additional functions of SREBPs in filamentous fungi, most importantly a role in maintenance of cell polarity.”
Quote in the paperSubstantial claim - Interpretationown data
These results suggest a blockage of C4 demethylation in the absence of SrbA in A. fumigatus.
“Consequently, these results suggest a blockage of C4 demethylation in the absence of SrbA in A. fumigatus.”
Quote in the paperSubstantial claim - Interpretationown data
Accumulation of 4-methylfecosterol and 4,4-dimethylergosta-8,24(28)-dien-3β-ol in the absence of SrbA suggests a blockage at ERG25 in the sterol biosynthesis pathway in SDW1.
“Specifically, the accumulation of 4-methylfecosterol and 4,4-dimethylergosta-8,24(28)-dien-3β-ol in the absence of SrbA suggests a blockage at ERG25 in the sterol biosynthesis pathway in SDW1.”
Quote in the paperSubstantial claim - Interpretationown data
SrbA is critical for normal hyphal branching and cell polarity in filamentous fungi by an undefined mechanism.
“and that SrbA is critical for normal hyphal branching and cell polarity in filamentous fungi by an undefined mechanism”
Quote in the paperSubstantial claim - Interpretationown data
TEM examination of the mutant suggested altered vesicle translocation or formation in the hyphae.
“Further examination of the mutant with TEM suggested altered vesicle translocation or formation in the hyphae.”
Quote in the paperSubstantial claim - Interpretationown data
Transcriptional profiling of SDW1 under hypoxia suggested that SrbA is involved in both early and late steps of the sterol biosynthesis pathway.
“Transcriptional profiling of SDW1 under hypoxia suggested that SrbA was involved in both early and late steps of the sterol biosynthesis pathway.”
Quote in the paperSubstantial claim - Interpretationreasoning
A. fumigatus contains complex regulatory mechanisms, of which SrbA is a part, for the production of ergosterol that remain to be elucidated.
“Thus, it appears that A. fumigatus contains complex regulatory mechanisms, of which SrbA is a part, for the production of ergosterol that remain to be elucidated.”
Quote in the paperNot a substantial claim - Interpretationown data
The altered cell polarity of the SrbA mutant did not significantly affect fungal growth.
“Though the altered cell polarity of the SrbA mutant may contribute to the virulence defect, the fact that SrbA null mutant displayed normal growth rates in vitro in standard laboratory growth conditions suggests to us that the altered cell polarity did not significantly affect fungal growth.”
Quote in the paperSubstantial claim - Interpretationreasoning
The observation that sterol biosynthesis was altered in normoxia, likely resulting in altered cell polarity, suggests that in molds, SrbA plays a significant role in the biology of filamentous fungi in normoxic conditions.
“Second, the observation that sterol biosynthesis was altered in normoxia, likely resulting in altered cell polarity, suggests that in molds, SrbA plays a significant role in the biology of filamentous fungi in normoxic conditions.”
Quote in the paperSubstantial claim - Interpretationreasoning
The inability of the SrbA null mutant to grow in hypoxic microenvironments is primarily responsible for the avirulent phenotype of the mutant.
“Consequently, we conclude that these observations strongly suggest that the inability of the SrbA null mutant to grow in hypoxic microenvironments is primarily responsible for the avirulent phenotype of the mutant.”
Quote in the paperSubstantial claim- The authors state this as an assumption: Sites of infection and inflammation in the neutropenic mouse model are hypoxic.
- The authors state this as an assumption: The hyper-inflammatory response in X-CGD mice generates significant hypoxia in the lung.
- Rests on an assumption: A. fumigatus must overcome significant hypoxia during pulmonary infections.
- Interpretationreasoning
SREBPs play critical roles in the biology of fungi that have important implications for fungal virulence and how we manage and treat invasive fungal infections.
“What is clear, however, is that SREBPs play critical roles in the biology of fungi that have important implications for fungal virulence and how we manage and treat invasive fungal infections.”
Quote in the paperSubstantial claim - Interpretationreasoning
The inability of the SrbA null mutant to grow in hypoxia prevents invasive disease from being established.
“First, and we believe most likely, the inability of the SrbA null mutant to grow in hypoxia prevents invasive disease from being established.”
Quote in the paperSubstantial claim- The authors state this as an assumption: Sites of infection and inflammation in the neutropenic mouse model are hypoxic.
- Rests on an assumption: A. fumigatus must overcome significant hypoxia during pulmonary infections.
- Interpretationreasoning
The virulence defect in the SrbA null mutant is due to its inability to grow in hypoxia.
“Taken together, we feel these observations strongly suggest that the virulence defect in the SrbA null mutant is due to its inability to grow in hypoxia.”
Quote in the paperSubstantial claim- The authors state this as an assumption: Sites of infection and inflammation in the neutropenic mouse model are hypoxic.
- Rests on an assumption: A. fumigatus must overcome significant hypoxia during pulmonary infections.
- Interpretationreasoning
The inability of the mutant to grow in hypoxia is related to the perturbation in sterol biosynthesis, a highly oxygen dependent pathway reported to require at least 22 molecules of oxygen.
“It is also likely then that the inability of the mutant to grow in hypoxia is related to the perturbation in sterol biosynthesis, a highly oxygen dependent pathway reported to require at least 22 molecules of oxygen.”
Quote in the paperSubstantial claim - Interpretationown data
SrbA mediates resistance to the azole class of antifungal drugs.
“An additional observation of clinical significance was the finding that SrbA mediates resistance to the azole class of antifungal drugs.”
Quote in the paperSubstantial claim - Premisecitation
X-CGD gp91phox−/− mice exhibit a hyper-inflammatory response when exposed to A. fumigatus and other Aspergillus species.
“These mice exhibit a hyper-inflammatory response when exposed to A. fumigatus and other Aspergillus species.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [45] DE Morgenstern, 1997, Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to <italic>Aspergillus fumigatus</italic>., J Exp Med source
Not checked in the free run.
- cites [46] JD Pollock, 1995, Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production., Nat Genet source
Not checked in the free run.
- Premisecitation
Hughes et al. (2007) identified 4-methyl sterols as the primary activating agent of Sre1 in S. pombe.
“Indeed, Hughes et al. (2007) have identified 4-methyl sterols as the primary activating agent of Sre1 in S. pombe [64].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [64] AL Hughes, 2007, 4-Methyl sterols regulate fission yeast SREBP-Scap under low oxygen and cell stress., J Biol Chem source
Not checked in the free run.
- Interpretationnone given
Based on current knowledge of the pathophysiology of IPA, the in vitro phenotypes observed in the SrbA mutant would not predict a role for this protein in A. fumigatus virulence.
“Based on our current knowledge of the pathophysiology of IPA, the in vitro phenotypes observed in the SrbA mutant would not predict a role for this protein in A. fumigatus virulence.”
Quote in the paperSubstantial claim - Interpretationown data
Limited mortality in X-CGD mice inoculated with the SrbA null mutant strongly suggests that the mutant cannot grow effectively in vivo to cause invasive disease.
“However, in contrast, we observed limited mortality in these mice when inoculated with the SrbA null mutant, strongly suggesting that the mutant simply cannot grow effectively in vivo to cause invasive disease.”
Quote in the paperSubstantial claim - Interpretationown data
As the infection progresses, SDW1 is incapable of continued hyphal growth despite the absence of NADPH oxidase in the X-CGD murine model.
“This result indicates that as the infection progresses, SDW1 is incapable of continued hyphal growth despite the absence of NADPH oxidase in this murine model.”
Quote in the paperSubstantial claim - Interpretationown data
Increased hypoxia prevents proliferation of fungal tissue in the absence of SrbA.
“This result confirms the importance of a functional NADPH oxidase in resistance to Aspergillus infections, and suggests that increased hypoxia prevents proliferation of fungal tissue in the absence of SrbA.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The hyper-inflammatory response in X-CGD mice generates significant hypoxia in the lung.
- May combine two claims. 30
- Classified as probably not a substantial claim. 35
- The quote only partly states this claim. 1
May combine two claims.
Findingown dataCEA10 and SDW2 showed resistance to Fluconazole as expected, while SDW1 growth was inhibited at the surprisingly low MIC of 1 μg/ml.
“while CEA10 and SDW2 showed resistance to Fluconazole as expected, SDW1 growth was inhibited at the surprisingly low MIC of 1 µg/ml (Figure 3).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAddition of exogenous ergosterol or lanosterol did not rescue the SDW1 growth defect or alter wild type growth morphology in hypoxia.
“Addition of exogenous ergosterol or lanosterol did not rescue the SDW1 growth defect or alter wild type growth morphology in hypoxia (data not shown).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn hypoxia, wild type strains displayed increased aerial hyphae, decreased conidia production, and consequently exhibited a fluffy colony morphology.
“In hypoxia, the wild type strains displayed increased aerial hyphae, decreased conidia production, and consequently exhibited a fluffy colony morphology (Figure 2B).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataSrbA is highly conserved amongst the filamentous fungi with putative orthologs found in plant pathogens such as Magnaporthe grisea and Alternaria brassicicola and saprophytic molds such as Neurospora crassa and Aspergillus nidulans.
“Additional BLAST analyses revealed that SrbA is highly conserved amongst the filamentous fungi with putative orthologs found in plant pathogens such as Magnaporthe grisea and Alternaria brassicicola and saprophytic molds such as Neurospora crassa and Aspergillus nidulans.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataSrbA is required for resistance to Fluconazole and Voriconazole, but not Amphotericin B or Caspofungin.
“we found that SrbA is required for resistance to Fluconazole and Voriconazole, but not Amphotericin B or Caspofungin”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAll 3 strains showed equivalent minimal inhibitory concentrations (MIC) to Amphotericin B (0.25 μg/ml) and Caspofungin (0.125 μg/ml).
“All 3 strains showed equivalent minimal inhibitory concentrations (MIC) to Amphotericin B (0.25 µg/ml) and Caspofungin (0.125 µg/ml).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe majority of X-CGD mice infected with SDW1 survived the infection and displayed no symptoms of IPA by day 14.
“Regardless, the majority of X-CGD mice infected with SDW1 survived the infection and displayed no symptoms of IPA by day 14.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe hyphal branching phenotype does not appear to alter the growth rate of the colony, which was comparable to the wild type under normoxic conditions.
“Interestingly, this phenotype does not appear to alter the growth rate of the colony, which was comparable to the wild type under normoxic conditions (Figure 2A).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataBoth SDW1 and CEA10 possessed significant amounts of ergosterol.
“Interestingly, both strains possessed significant amounts of ergosterol (Figure 7).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataExamination of the SrbA null mutant colony morphology revealed abnormal branching at the hyphal tips in normoxia and an inability of hyphal growth in hypoxia.
“Our examination of the SrbA null mutant colony morphology subsequently revealed abnormal branching at the hyphal tips in normoxia and an inability of hyphal growth in hypoxia.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataSDW1 hyphal tips display hyper-branching and a blunted abnormal morphological phenotype.
“SDW1 hyphal tips display hyper-branching and a “blunted” abnormal morphological phenotype (Figure 4).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe ratio of C-4 methylated sterols to ergosterol in the absence of SrbA is 1.94, whereas no C-4 methylated sterols accumulated in the wild type.
“The ratio of C-4 methylated sterols to ergosterol in the absence of SrbA is 1.94 whereas no C-4 methylated sterols accumulated in the wild type.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataHistopathology on day 4 revealed extensive growth and proliferation of wild type and reconstituted SDW2, but minimal fungal growth and proliferation in mice infected with SDW1.
“Histopathology on day 4 of the infection, however, revealed extensive growth and proliferation of the wild type and reconstituted SDW2 strain, but minimal fungal growth and proliferation in mice infected with the SrbA null mutant SDW1 (Figure 11).”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Findingown dataLung homogenates from X-CGD mice revealed that viable SDW1 fungus was recoverable at day 4.
“Lung homogenates from these mice also revealed that viable SDW1 fungus was recoverable from these mice at this time point.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataSDW1 was significantly more susceptible to Voriconazole and showed a MIC of only 0.012 μg/ml.
“Similar to the results with Fluconazole, SDW1 was significantly more susceptible to Voriconazole and showed a MIC of only 0.012 µg/ml (Figure 3).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThis phenotype (electron dense objects) was observed in over 50% of the SDW1 hyphae examined and never observed in the wild type strain.
“This phenotype was observed in over 50% of the SDW1 hyphae examined and never observed in the wild type strain.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataNo mock-infected animals perished in either murine model in all experiments.
“No mock infected animals perished in either murine model in all experiments.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataNo difference in susceptibility testing results was observed between 24 and 48 h.
“No difference in results was observed between 24 and 48 h.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAspergillus fumigatus is a normally benign saprophytic fungus that may cause an often lethal invasive disease in immunocompromised patients, invasive pulmonary aspergillosis (IPA).
“Aspergillus fumigatus is a normally benign saprophytic fungus that may cause an often lethal invasive disease in immunocompromised patients, invasive pulmonary aspergillosis (IPA) [1],[2].”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSwitching from aerobic respiration to various forms of anaerobic respiration to deal with low oxygen levels has been implicated as an important virulence attribute in several prokaryotic pathogens.
“switching from aerobic respiration to various forms of anaerobic respiration to deal with low oxygen levels has been implicated as an important virulence attribute in several prokaryotic pathogens [18],[19]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [18] I Smith, 2003, <italic>Mycobacterium tuberculosis</italic> pathogenesis and molecular determinants of virulence., Clin Microbiol Rev source
Not checked in the free run.
- cites [19] DJ Richardson, 2000, Bacterial respiration: a flexible process for a changing environment., Microbiology source
Not checked in the free run.
May combine two claims.
PremisecitationSre1 is required for adaptation to hypoxia and regulated approximately 68% of the genes transcriptionally induced greater than 2-fold in response to anaerobic conditions.
“Sre1 was found to be required for adaptation to hypoxia and regulated approximately 68% of the genes transcriptionally induced greater than 2-fold in response to anaerobic conditions [31].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [31] BL Todd, 2006, Sterol regulatory element binding protein is a principal regulator of anaerobic gene expression in fission yeast., Mol Cell Biol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe SREBP pathway mediated by Sre1 and Scp1 in Cryptococcus neoformans is crucial for adaptation to hypoxia and sterol biosynthesis.
“As in fission yeast, the SREBP pathway mediated by Sre1 and Scp1 in C. neoformans was crucial for adaptation to hypoxia and sterol biosynthesis.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [32] YC Chang, 2007, Sre1p, a regulator of oxygen sensing and sterol homeostasis, is required for virulence in <italic>Cryptococcus neoformans</italic>., Mol Microbiol source
Not checked in the free run.
- cites [33] CD Chun, 2007, A Link between virulence and homeostatic responses to hypoxia during infection by the human fungal pathogen <italic>Cryptococcus neoformans</italic>., PLoS Pathog source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
InterpretationreasoningPathologic lesions from A. fumigatus infection likely represent areas of poor oxygen availability to the pathogen and host.
“These pathologic lesions also likely represent areas of poor oxygen availability to the pathogen and host.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA novel mechanism of hypoxia adaptation mediated by sterol regulatory element-binding proteins (SREBPs) was characterized in Schizosaccharomyces pombe.
“Recently, a novel mechanism of hypoxia adaptation mediated by a highly conserved family of transcription factors, sterol regulatory element-binding proteins (SREBPs), was characterized in fission yeast, Schizosaccharomyces pombe [25].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [25] AL Hughes, 2005, SREBP pathway responds to sterols and functions as an oxygen sensor in fission yeast., Cell source
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductown dataAll strains were rigorously confirmed with Southern blot and PCR analyses.
“All strains were rigorously confirmed with Southern blot (Figure 1) and PCR analyses (data not shown).”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
PremisecitationC. neoformans Sre1/Scp1 mutants failed to proliferate in host tissue, failed to cause fatal meningoencephalitis, and displayed hypersensitivity to the azole class of antifungal drugs.
“these mutants also failed to proliferate in host tissue, failed to cause fatal meningoencephalitis, and displayed hypersensitivity to the azole class of antifungal drugs [32],[33]”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [32] YC Chang, 2007, Sre1p, a regulator of oxygen sensing and sterol homeostasis, is required for virulence in <italic>Cryptococcus neoformans</italic>., Mol Microbiol source
Not checked in the free run.
- cites [33] CD Chun, 2007, A Link between virulence and homeostatic responses to hypoxia during infection by the human fungal pathogen <italic>Cryptococcus neoformans</italic>., PLoS Pathog source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationThe mechanisms utilized by A. fumigatus to survive and cause disease in immunocompromised hosts are not fully understood.
“Yet, the mechanisms utilized by A. fumigatus to survive and cause disease in immunocompromised hosts are not fully understood [4].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [4] TM Hohl, 2007, <italic>Aspergillus fumigatus</italic>: principles of pathogenesis and host defense., Eukaryot Cell source
Not checked in the free run.
May combine two claims.
Interpretationown dataOur results confirm that some roles of SREBPs in filamentous fungi are conserved with yeast, including the response to hypoxia, sterol biosynthesis, and susceptibility to the azole class of antifungal drugs.
“Our results confirm that some roles of SREBPs in filamentous fungi are conserved with yeast including, the response to hypoxia, sterol biosynthesis, and susceptibility to the azole class of antifungal drugs.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationC. neoformans lacks an apparent Insig homolog and the Insig homolog in S. pombe does not appear to be required for regulation of SREBP signalling.
“Interestingly, C. neoformans lacks an apparent Insig homolog and the Insig homolog in S. pombe does not appear to be required for regulation of SREBP signalling [25],[32].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [25] AL Hughes, 2005, SREBP pathway responds to sterols and functions as an oxygen sensor in fission yeast., Cell source
Not checked in the free run.
- cites [32] YC Chang, 2007, Sre1p, a regulator of oxygen sensing and sterol homeostasis, is required for virulence in <italic>Cryptococcus neoformans</italic>., Mol Microbiol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn the yeast S. pombe and C. neoformans, Sre1 is regulated post-translationally in response to sterol biosynthesis perturbation that occurs in low oxygen environments.
“In the yeast S. pombe and C. neoformans, it seems clear that Sre1 is regulated post-translationally in response to sterol biosynthesis perturbation that occurs in low oxygen environments.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningOur finding that the SrbA null mutant in A. fumigatus accumulates 4-methyl sterols may suggest that these sterols are the trigger for SrbA activation in A. fumigatus.
“Thus, our finding that the SrbA null mutant in A. fumigatus accumulates 4-methyl sterols may also suggest that these sterols are the trigger for SrbA activation in A. fumigatus.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThe inability of the SrbA null mutant to adapt to hypoxic conditions results in rapid cessation of invasive growth and a lack of lethal disease.
“Thus, we believe that A. fumigatus must overcome significant hypoxia during pulmonary infections, and the inability of the SrbA null mutant to adapt to hypoxic conditions results in rapid cessation of invasive growth and a lack of lethal disease.”
Quote in the paperSubstantial claim- The authors state this as an assumption: Sites of infection and inflammation in the neutropenic mouse model are hypoxic.
- Rests on an assumption: A. fumigatus must overcome significant hypoxia during pulmonary infections.
May combine two claims.
InterpretationreasoningGrowth of the fungus was halted and immune effector cells present in the immunosuppressed mice were able to clear the infection.
“These two results suggest that growth of the fungus was halted and what immune effector cells present in the immunosuppressed mice were able to clear the infection.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationown dataSrbA may be transcriptionally regulated in molds.
“This suggests that SrbA may be transcriptionally regulated in molds.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA. fumigatus strain CEA17 is a uracil-auxotrophic (pyrG1) mutant of A. fumigatus strain CEA10.
“A. fumigatus strain CEA17 is a uracil-auxotrophic (pyrG1) mutant of A. fumigatus strain CEA10 [67],[68].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [67] C D'Enfert, 1996, Attenuated virulence of uridine-uracil auxotrophs of <italic>Aspergillus fumigatus</italic>., Infect Immun source
Not checked in the free run.
- cites [68] C d'Enfert, 1996, Selection of multiple disruption events in <italic>Aspergillus fumigatus</italic> using the orotidine-5′-decarboxylase gene, <italic>pyrG</italic>, as a unique transformation marker., Curr Genet source
Not checked in the free run.
May combine two claims.
InterpretationreasoningOnce hypoxia is generated during Aspergillus infection, the SrbA null mutant can no longer grow and proliferate, allowing immune effector cells to clear the infection.
“Once hypoxia is generated during Aspergillus infection, the mutant simply can no longer grow and proliferate, allowing what immune effector cells that remain functional the ability to ultimately clear the infection.”
Quote in the paperSubstantial claim- The authors state this as an assumption: Sites of infection and inflammation in the neutropenic mouse model are hypoxic.
- Rests on an assumption: A. fumigatus must overcome significant hypoxia during pulmonary infections.
Classified as probably not a substantial claim.
PremisecitationTakeshita et al. (2008) observed that localization of key deposition proteins involved in polarized growth at the hyphal tip requires apical sterol-rich membranes.
“Interestingly, Takeshita et al. (2008) recently observed that localization of key deposition proteins involved in polarized growth at the hyphal tip requires apical sterol-rich membranes [52].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [52] N Takeshita, 2008, Apical Sterol-rich Membranes Are Essential for Localizing Cell End Markers That Determine Growth Directionality in the Filamentous Fungus <italic>Aspergillus nidulans</italic>., Mol Biol Cell source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn mammals, Insig is a key regulator of SREBP function where it binds to SCAP and prevents SREBP cleavage in the presence of sterols by maintaining the SREBP-SCAP complex in the endoplasmic reticulum membrane.
“In mammals, Insig is a key regulator of SREBP function where it binds to SCAP and prevents SREBP cleavage in the presence of sterols by maintaining the SREBP-SCAP complex in the endoplasmic reticulum membrane [65],[66].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [65] LJ Engelking, 2006, Severe facial clefting in Insig-deficient mouse embryos caused by sterol accumulation and reversed by lovastatin., J Clin Invest source
Not checked in the free run.
- cites [66] T Yang, 2002, Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER., Cell source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationDifferences in the immunosuppression regimen can significantly affect the outcome of infection.
“Currently, it is unclear what specific components of the immune system are affected in this model, but it is clear that differences in the immunosuppression regimen can significantly affect the outcome of infection [56],[57].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [56] V Balloy, 2005, Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis., Infect Immun source
Not checked in the free run.
- cites [57] SD Stephens-Romero, 2005, The pathogenesis of fatal outcome in murine pulmonary aspergillosis depends on the neutrophil depletion strategy., Infect Immun source
Not checked in the free run.
May combine two claims.
Interpretationown dataThe SrbA null mutant was virtually avirulent in two distinct murine models of IPA despite a normal growth rate of the fungus in standard laboratory conditions.
“However, the SrbA null mutant was virtually avirulent in two distinct murine models of IPA despite a normal growth rate of the fungus in standard laboratory conditions.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningWhile aspects of SrbA signalling in filamentous fungi may be conserved in yeast and mammals, significant differences exist in molds that remain to be elucidated.
“Taken together, these results suggest that while aspects of SrbA signalling in filamentous fungi may be conserved in yeast and mammals, it is likely that significant differences exist in molds that remain to be elucidated.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationHIF1 in humans responds transcriptionally to hypoxia, but its activity is primarily post-translationally regulated.
“However, HIF1 in humans also responds transcriptionally to hypoxia, but its activity is primarily post-translationally regulated [62],[63].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [62] GL Semenza, 1999, Regulation of mammalian O<sub>2</sub> homeostasis by hypoxia-inducible factor 1., Annu Rev Cell Dev Biol source
Not checked in the free run.
- cites [63] RS Belaiba, 2007, Hypoxia up-regulates hypoxia-inducible factor-1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth muscle cells., Mol Biol Cell source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAt the apex of hyphae in filamentous fungi, the Spitzenkörper is an accumulation of vesicles that is critical for growth directionality.
“At the apex of hyphae in filamentous fungi, the Spitzenkörper is an accumulation of vesicles that is critical for growth directionality [50],[51].”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA relationship between mitochondria function, sterol homeostasis, and azole drug resistance has been observed in the yeast S. cerevisiae and Candida glabrata.
“Second, a relationship between mitochondria function, sterol homeostasis, and azole drug resistance has been observed in the yeast S. cerevisiae and Candida glabrata [60],[61].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [60] R Kaur, 2004, Functional genomic analysis of fluconazole susceptibility in the pathogenic yeast <italic>Candida glabrata</italic>: roles of calcium signaling and mitochondria., Antimicrob Agents Chemother source
Not checked in the free run.
- cites [61] DP Kontoyiannis, 2000, Modulation of fluconazole sensitivity by the interaction of mitochondria and erg3p in <italic>Saccharomyces cerevisiae</italic>., J Antimicrob Chemother source
Not checked in the free run.
May combine two claims.
Interpretationown dataEven though the ergosterol biosynthesis pathway appears blocked at ERG25 in the SrbA mutant, alternative mechanisms exist for A. fumigatus to produce ergosterol in the absence of SrbA and presumably ERG25 activity.
“Thus, even though the ergosterol biosynthesis pathway appears blocked at ERG25 in the SrbA mutant, alternative mechanisms exist for A. fumigatus to produce ergosterol in the absence of SrbA and presumably ERG25 activity.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenMicroarray data for each strain represent six independent experiments and include three dye swaps.
“Data for each strain represents six independent experiments and includes three dye swaps.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAll animal experiments were repeated in duplicate with similar results.
“All animal experiments were repeated in duplicate with similar results.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenTransformants were initially screened by PCR to identify potential homologous recombination events at the srbA locus.
“Transformants were initially screened by PCR to identify potential homologous recombination events at the srbA locus.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataMacrophage assays were performed with triplicate wells and repeated two times for each A. fumigatus strain.
“Experiments were performed with triplicate wells and repeated two times for each A. fumigatus strain.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataMurine virulence experiments were repeated in duplicates with similar results.
“Experiments were repeated in duplicates with similar results.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe oxidative stress assay was repeated three times for each H2O2 concentration.
“The assay was repeated three times for each concentration.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenA Delta cutoff in SAM that captured the maximum number of significant genes with a false discovery rate of zero was used.
“A Delta cutoff in SAM that captured the maximum number of significant genes with a false discovery rate of zero was utilized.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningThe P values reported are always the conservative values.
“The P values we report are always the conservative values.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenRNA integrity was confirmed with an Agilent Technologies Bioanalyzer.
“RNA integrity was confirmed with an Agilent Technologies Bioanalyzer.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductnone givenEach transformant was streaked at least twice to obtain colonies from single conidia, eliminating the chance of heterokaryons.
“To eliminate the chance of heterokaryons, each transformant was streaked with sterile toothpicks a minimum of two times to obtain colonies from single conidia.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductcitationHomologous recombination at the srbA locus in transformants was confirmed by Southern analysis.
“Homologous recombination was confirmed by Southern analysis with the digoxigenin labeling system (Roche Molecular Biochemicals, Mannheim, Germany) as previously described [71].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [71] RA Cramer, 2003, Cloning of a gene encoding an Alt a 1 isoallergen differentially expressed by the necrotrophic fungus <italic>Alternaria brassicicola</italic> during Arabidopsis infection., Appl Environ Microbiol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenConidia germination counting was repeated three times for each strain, and the mean and standard deviation are reported.
“Counting was repeated three times for each strain and the mean and standard deviation are reported.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataWhen a deviation from normal distribution was suspected, both the t test and Mann-Whitney test indicated the same results.
“In those cases, we found that both the t test and Mann-Whitney test indicated the same results (i.e., both indicated significance or insignificance); however, typically one test gave a more conservative (larger, but still <0.01) P value.”
Quote in the paperNot a substantial claim
The authors state this as an assumption.
Sites of infection and inflammation in the neutropenic mouse model are hypoxic.
“We hypothesize that these sites of infection and inflammation in this model are hypoxic.”
The authors state this as an assumption.
The hyper-inflammatory response in X-CGD mice generates significant hypoxia in the lung.
“with the hypothesis that the hyper-inflammatory response would generate significant hypoxia in the lung”
The paper relies on this without support.
A. fumigatus must overcome significant hypoxia during pulmonary infections.
“we believe that A. fumigatus must overcome significant hypoxia during pulmonary infections”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In A. fumigatus and C. neoformans, expression of cyp51A/ERG11 in response to azole exposure is regulated by the SREBP SrbA and Sre1, respectively.
“In A. fumigatus and C. neoformans, expression of cyp51A /ERG11 in response to azole exposure is regulated by the sterol regulatory element-binding protein (SREBP), SrbA and Sre1, respectively28,29.”
From Molecular mechanisms governing antifungal drug resistance (2023) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Key sterol is identified as both dimethylated and demethylated
MinorThe results identify an accumulated sterol as 4,4-dimethylated, while the Figure 7 key identifies the corresponding sterol as 4,4-demethylated. Those descriptions disagree about the methyl groups central to the proposed C-4 demethylation defect.
“the accumulation of 4-methylfecosterol and 4,4-dimethylergosta-8,24(28)-dien-3β-ol in the absence of SrbA”
“H- 4,4-demethylergosta-8,24(28)-dien-3β-ol.”
Rox1p and Mot3p are said to repress and induce hypoxia-adaptation genes
MinorThe introduction first says Rox1p and Mot3p down-regulate genes needed for hypoxia adaptation, then says their expression under hypoxia leads to induction of those genes.
“the transcriptional repressors Rox1p and Mot3p, that down-regulate genes required for hypoxia adaptation [21].”
“However, in hypoxic conditions, Rox1p and Mot3p are expressed and this leads to transcriptional induction of genes involved in hypoxia adaptation [22].”
Cites
THE USE OF LEAD CITRATE AT HIGH pH AS AN ELECTRON-OPAQUE STAIN IN ELECTRON MICROSCOPY
Reynolds, E. S. (1963) · The Journal of Cell Biology · doi:10.1083/jcb.17.1.208 · Cited by 24,938 · see citing works
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F. Z., Miled, S. B., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,785 · see citing works
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568 · see citing works
<i>Aspergillus fumigatus</i> and Aspergillosis
Latgé, J.-P. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.2.310 · Cited by 2,307 · see citing works
Regulation of Mammalian O <sub>2</sub> Homeostasis by Hypoxia-Inducible Factor 1
Semenza, G. L. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.551 · Cited by 1,914 · see citing works
Aspergillus fumigatus and Aspergillosis in 2019
Latgé, J.-P., & Chamilos, G. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00140-18 · Cited by 1,400 · see citing works
Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus
Nierman, W. C., Pain, A., Anderson, M. J., Wortman, J. R., Kim, H. S., Arroyo, J., Berriman, M., Abe, K., Archer, D. B., Bermejo, C., et al. (2005) · Nature · doi:10.1038/nature04332 · Cited by 1,391 · see citing works
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353 · see citing works
<i>Mycobacterium tuberculosis</i>Pathogenesis and Molecular Determinants of Virulence
Smith, I. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.3.463-496.2003 · Cited by 1,154 · see citing works
Wenger, R. H. (2002) · The FASEB Journal · doi:10.1096/fj.01-0944rev · Cited by 1,135 · see citing works
Maxwell, P. H., Dachs, G. U., Gleadle, J. M., Nicholls, L. G., Harris, A. L., Stratford, I. J., Hankinson, O., Pugh, C. W., & Ratcliffe, P. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8104 · Cited by 1,084 · see citing works
Crucial Step in Cholesterol Homeostasis
Yang, T., Espenshade, P. J., Wright, M. E., Yabe, D., Gong, Y., Aebersold, R., Goldstein, J. L., & Brown, M. S. (2002) · Cell · doi:10.1016/s0092-8674(02)00872-3 · Cited by 987 · see citing works
Pollock, J. D., Williams, D. A., Gifford, M. A. C., Li, L. L., Du, X., Fisherman, J., Orkin, S. H., Doerschuk, C. M., & Dinauer, M. C. (1995) · Nature Genetics · doi:10.1038/ng0295-202 · Cited by 921 · see citing works
LaeA, a Regulator of Secondary Metabolism in <i>Aspergillus</i> spp
Bok, J. W., & Keller, N. P. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.2.527-535.2004 · Cited by 902 · see citing works
Trends in Mortality Due to Invasive Mycotic Diseases in the United States, 1980–1997
McNeil, M. M., Nash, S. L., Hajjeh, R. A., Phelan, M. A., Conn, L. A., Plikaytis, B. D., & Warnock, D. W. (2001) · Clinical Infectious Diseases · doi:10.1086/322606 · Cited by 657 · see citing works
Regulation of Sterol Synthesis in Eukaryotes
Espenshade, P. J., & Hughes, A. L. (2007) · Annual Review of Genetics · doi:10.1146/annurev.genet.41.110306.130315 · Cited by 593 · see citing works
Richardson, D. J. (2000) · Microbiology · doi:10.1099/00221287-146-3-551 · Cited by 544 · see citing works
Sabatelli, F., Patel, R., Mann, P. A., Mendrick, C. A., Norris, C. C., Hare, R., Loebenberg, D., Black, T. A., & McNicholas, P. M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00163-06 · Cited by 491 · see citing works
Shimizu, K., & Keller, N. P. (2001) · Genetics · doi:10.1093/genetics/157.2.591 · Cited by 445 · see citing works
Protoplasmic organization of hyphal tips among fungi: vesicles and Spitzenkorper.
Grove, S. N., & Bracker, C. E. (1970) · Journal of Bacteriology · doi:10.1128/jb.104.2.989-1009.1970 · Cited by 432 · see citing works
BelAiba, R. S., Bonello, S., Zähringer, C., Schmidt, S., Hess, J., Kietzmann, T., & Görlach, A. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-04-0391 · Cited by 423 · see citing works
Nakayama, K., Frew, I. J., Hagensen, M. K., Skals, M., Habelhah, H., Bhoumik, A., Kadoya, T., Erdjument‐Bromage, H., Tempst, P., Frappell, P. B., et al. (2004) · Cell · doi:10.1016/j.cell.2004.06.001 · Cited by 405 · see citing works
Briggs, M. R., Yokoyama, C., Wang, X., Brown, M. S., & Goldstein, J. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85265-1 · Cited by 401 · see citing works
Aspergillus fumigatus: saprophyte or pathogen?
Tekaia, F., & Latgé, J.-P. (2005) · Current Opinion in Microbiology · doi:10.1016/j.mib.2005.06.017 · Cited by 387 · see citing works
Morgenstern, D. E., Gifford, M. A. C., Li, L. L., Doerschuk, C. M., & Dinauer, M. C. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.2.207 · Cited by 370 · see citing works
The SREBP pathway — insights from insigs and insects
Rawson, R. B. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1174 · Cited by 323 · see citing works
SREBP pathway responds to sterols and functions as an oxygen sensor in fission yeast.
Hughes, A. L., Todd, B. L., & Espenshade, P. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.012 · Cited by 320 · see citing works
Wang, X., Briggs, M. R., Hua, X., Yokoyama, C., Goldstein, J. L., & Brown, M. S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85266-3 · Cited by 299 · see citing works
Thiel, M., Choukèr, A., Ohta, A., Jackson, E., Caldwell, C. C., Smith, P. T., Lukashev, D. E., Bittmann, I., & Sitkovsky, M. V. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030174 · Cited by 287 · see citing works
Upc2p and Ecm22p, Dual Regulators of Sterol Biosynthesis in <i>Saccharomyces cerevisiae</i>
Vik, Å., & Rine, J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.19.6395-6405.2001 · Cited by 277 · see citing works
Calcineurin Controls Growth, Morphology, and Pathogenicity in <i>Aspergillus fumigatus</i>
Steinbach, W. J., Cramer, R. A., Perfect, B. Z., Asfaw, Y. G., Sauer, T. C., Najvar, L. K., Kirkpatrick, W. R., Patterson, T. F., Benjamin, D. K., Heitman, J., et al. (2006) · Eukaryotic Cell · doi:10.1128/ec.00139-06 · Cited by 264 · see citing works
Self-citationDiagnosis of Invasive Septate Mold Infections
Tarrand, J. J., Lichterfeld, M. D., Warraich, I. I., Luna, M. A., Han, X. Y., May, G. S., & Kontoyiannis, D. P. (2003) · American Journal of Clinical Pathology · doi:10.1309/exbvyaupenbm285y · Cited by 238 · see citing works
MacPherson, S., Akache, B., Weber, S., De Deken, X., Raymond, M., & Turcotte, B. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.1745-1752.2005 · Cited by 238 · see citing works
<i>Aspergillus fumigatus</i> : Principles of Pathogenesis and Host Defense
Hohl, T. M., & Feldmesser, M. (2007) · Eukaryotic Cell · doi:10.1128/ec.00274-07 · Cited by 237 · see citing works
Dunkel, N., Liu, T. T., Barker, K. S., Homayouni, R., Morschhäuser, J., & Rogers, P. D. (2008) · Eukaryotic Cell · doi:10.1128/ec.00103-08 · Cited by 236 · see citing works
Balloy, V., Huerre, M., Latgé, J.-P., & Chignard, M. (2005) · Infection and Immunity · doi:10.1128/iai.73.1.494-503.2005 · Cited by 231 · see citing works
Role of <i>Candida albicans</i> Transcription Factor Upc2p in Drug Resistance and Sterol Metabolism
Silver, P. M., Oliver, B. G., & White, T. C. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.6.1391-1397.2004 · Cited by 216 · see citing works
Chang, Y. C., Bien, C. M., Lee, H., Espenshade, P. J., & Kwon‐Chung, K. J. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05676.x · Cited by 212 · see citing works
Cramer, R. A., Gamcsik, M. P., Brooking, R. M., Najvar, L. K., Kirkpatrick, W. R., Patterson, T. F., Balibar, C. J., Graybill, J. R., Perfect, J. R., Abraham, S. N., et al. (2006) · Eukaryotic Cell · doi:10.1128/ec.00049-06 · Cited by 209 · see citing works
Self-citationWhat determines growth direction in fungal hyphae?
Riquelme, M., Reynaga-Peña, C. G., Gierz, G., & Bartnicki-Garcı́a, S. (1998) · Fungal Genetics and Biology · doi:10.1006/fgbi.1998.1074 · Cited by 207 · see citing works
Li, Z., & Hach, A. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050442 · Cited by 206 · see citing works
Chun, C. D., Liu, O. W., & Madhani, H. D. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030022 · Cited by 181 · see citing works
d'Enfert, C. (1996) · Current Genetics · doi:10.1007/s002940050103 · Cited by 178 · see citing works
Kwast, K. E., Burke, P. V., Staahl, B. T., & Poyton, R. O. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5446 · Cited by 175 · see citing works
SREBPs: sterol-regulated transcription factors
Espenshade, P. J. (2006) · Journal of Cell Science · doi:10.1242/jcs.02866 · Cited by 174 · see citing works
Todd, B. L., Stewart, E. V., Burg, J. S., Hughes, A. L., & Espenshade, P. J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2817-2831.2006 · Cited by 172 · see citing works
Kaur, R., Castaño, I., & Cormack, B. P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1600-1613.2004 · Cited by 167 · cited 1× · see citing works
“cerevisiae and Candida glabrata [60,61].”
Ergosterol biosynthesis pathway in Aspergillus fumigatus
Alcázar‐Fuoli, L., Mellado, E., García‐Effrón, G., López, J. F., Grimalt, J. O., Cuenca-Estrella, J. M., & Rodrı́guez-Tudela, J. L. (2007) · Steroids · doi:10.1016/j.steroids.2007.11.005 · Cited by 163 · see citing works
Sterol-Rich Plasma Membrane Domains in Fungi
Álvarez, F. J., Douglas, L. M., & Konopka, J. B. (2007) · Eukaryotic Cell · doi:10.1128/ec.00008-07 · Cited by 163 · see citing works
Takeshita, N., Higashitsuji, Y., Konzack, S., & Fischer, R. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-06-0523 · Cited by 163 · see citing works
Da Silva Ferreira, M. E., Colombo, A. L., Paulsen, I., Ren, Q., Wortman, J., Huang, J., Goldman, M. H. S., & Goldman, G. H. (2005) · Medical Mycology · doi:10.1080/13693780400029114 · Cited by 158 · see citing works
Concepts of oxygen transport at the microcirculatory level
Dewhirst, M. W. (1998) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(98)80040-4 · Cited by 155 · see citing works
Balasubramanian, B., Lowry, C. V., & Zitomer, R. S. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6071 · Cited by 140 · see citing works
Formation and release of purine catabolites during hypoperfusion, anoxia, and ischemia
Belle, H. V., Goossens, F., & Wynants, J. (1987) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1987.252.5.h886 · Cited by 140 · see citing works
Stephens-Romero, S. D., Mednick, A. J., & Feldmesser, M. (2005) · Infection and Immunity · doi:10.1128/iai.73.1.114-125.2005 · Cited by 131 · see citing works
Liebmann, B., Gattung, S., Jahn, B., & Brakhage, A. A. (2003) · Molecular Genetics and Genomics · doi:10.1007/s00438-003-0852-0 · Cited by 123 · see citing works
Attenuated virulence of uridine-uracil auxotrophs of Aspergillus fumigatus
D'Enfert, C., Diaquin, M., Delit, A., Wuscher, N., Debeaupuis, J. P., Huerre, M., & Latge, J. P. (1996) · Infection and Immunity · doi:10.1128/iai.64.10.4401-4405.1996 · Cited by 123 · see citing works
A Role for Sterol Levels in Oxygen Sensing in <i>Saccharomyces cerevisiae</i>
Davies, B. S. J., & Rine, J. (2006) · Genetics · doi:10.1534/genetics.106.059964 · Cited by 123 · see citing works
Aspergillus fumigatus : Growth and virulence
Rhodes, J. C. (2006) · Medical Mycology · doi:10.1080/13693780600779419 · Cited by 120 · see citing works
Vasconcelles, M. J., Jiang, Y., McDaid, K., Gilooly, L., Wretzel, S., Porter, D. L., Martin, C. E., & Goldberg, M. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009546200 · Cited by 114 · see citing works
SREBPs: sterol-regulated transcription factors
Espenshade, P. J. (2006) · Journal of Cell Science · doi:10.1242/jcs02866 · Cited by 108 · see citing works
Simmen, H., Battaglia, H., Giovanoli, P., & Blaser, J. (1994) · Infection · doi:10.1007/bf01715494 · Cited by 100 · see citing works
Gachotte, D. J., Sen, S. E., Eckstein, J. A., Barbuch, R. J., Krieger, M., Ray, B. D., & Bard, M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12655 · Cited by 99 · see citing works
Self-citationEngelking, L. J., Evers, B. M., Richardson, J. A., Goldstein, J. L., Brown, M. S., & Liang, G. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28988 · Cited by 82 · see citing works
Reeves, E. P., Reiber, K., Neville, C., Scheibner, O., Kavanagh, K., & Doyle, S. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05315.x · Cited by 70 · see citing works
Kontoyiannis, D. P. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.2.191 · Cited by 70 · see citing works
Phylogenomic analysis of non-ribosomal peptide synthetases in the genus Aspergillus
Cramer, R. A., Stajich, J. E., Yamanaka, Y., Dietrich, F. S., Steinbach, W. J., & Perfect, J. R. (2006) · Gene · doi:10.1016/j.gene.2006.07.008 · Cited by 66 · see citing works
Self-citationShianna, K. V., Dotson, W. D., Tove, S. R., & Parks, L. W. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.3.830-834.2001 · Cited by 63 · see citing works
4-Methyl sterols regulate fission yeast SREBP-Scap under low oxygen and cell stress.
Hughes, A. L., Lee, C.-Y. S., Bien, C. M., & Espenshade, P. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701326200 · Cited by 60 · see citing works
Alcázar‐Fuoli, L., Mellado, E., García‐Effrón, G., Buitrago, M. J., López, J. F., Grimalt, J. O., Cuenca-Estrella, J. M., & Rodrı́guez-Tudela, J. L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.453-460.2006 · Cited by 57 · see citing works
Xiong, Q., Hassan, S. A., Wilson, W. K., Han, X. Y., May, G. S., Tarrand, J. J., & Matsuda, S. P. T. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.518-524.2005 · Cited by 55 · see citing works
Interstitial Transudate Purines in Normoxic and Hypoxic Immature and Mature Rabbit Hearts
Matherne, G. P., Headrick, J. P., Coleman, S. D., & Berne, R. M. (1990) · Pediatric Research · doi:10.1203/00006450-199010000-00010 · Cited by 52 · see citing works
Marr, K. A., Koudadoust, M., Black, M. C., & Balajee, S. A. (2001) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.8.6.1240-1247.2001 · Cited by 51 · see citing works
Rox1 mediated repression. Oxygen dependent repression in yeast.
Kastaniotis, A. J., & Zitomer, R. S. (2000) · PubMed · Cited by 50 · see citing works
Tarrand, J. J., Han, X. Y., Kontoyiannis, D. P., & May, G. S. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.1.382-386.2005 · Cited by 49 · see citing works
Balasubramanian, B., Lowry, C. V., & Zitomer, R. S. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6071-6078.1993 · Cited by 48 · see citing works
Arnold, F., West, D. C., & Kumar, S. (1987) · PubMed · Cited by 47 · see citing works
Warn, P. A. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh153 · Cited by 46 · see citing works
Kastaniotis, A. J., & Zitomer, R. S. (2002) · Advances in experimental medicine and biology · doi:10.1007/0-306-46825-5_18 · Cited by 44 · see citing works
Cramer, R. A., & Lawrence, C. B. (2003) · Applied and Environmental Microbiology · doi:10.1128/aem.69.4.2361-2364.2003 · Cited by 41 · see citing works
Self-citationRegulation of sterol metabolism in Candida albicans by the UPC2 gene
Silver, P. M., & White, T. C. (2005) · Biochemical Society Transactions · doi:10.1042/bst20051215 · Cited by 28 · see citing works
Perkhofer, S., Jost, D., Dierich, M. P., & Lass‐Flörl, C. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01572-07 · Cited by 27 · see citing works
Jahn, B., Rampp, A., Dick, C., Jahn, A., Palmer, M., & Bhakdi, S. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.10.2569 · Cited by 27 · see citing works
Regulation of sterol metabolism in Candida albicans by the UPC2 gene
White, T. C., & Silver, P. M. (2005) · Biochemical Society Transactions · doi:10.1042/bst0331215 · Cited by 19 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Aspergillus fumigatus and Aspergillosis in 2019
Latgé, J.-P., & Chamilos, G. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00140-18 · Cited by 1,400 · see citing works
Pathogenesis of <i>Aspergillus fumigatus</i> in Invasive Aspergillosis
Dagenais, T. R. T., & Keller, N. P. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00055-08 · Cited by 993 · see citing works
Regulatory circuitry governing fungal development, drug resistance, and disease.
Shapiro, R. S., Robbins, N., & Cowen, L. E. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00045-10 · Cited by 576 · see citing works
Antifungal drug resistance: evolution, mechanisms and impact
Revie, N. M., Iyer, K. R., Robbins, N., & Cowen, L. E. (2018) · Current Opinion in Microbiology · doi:10.1016/j.mib.2018.02.005 · Cited by 528 · see citing works
Aspergillus fumigatus morphology and dynamic host interactions
van de Veerdonk, F. L., Gresnigt, M. S., Romani, L., Netea, M. G., & Latgé, J.-P. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.90 · Cited by 490 · see citing works
The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin
Hoenigl, M., Sprute, R., Egger, M., Arastehfar, A., Cornely, O. A., Krause, R., Lass-Flörl, C., Prattes, J., Spec, A., Thompson, G. R., et al. (2021) · Drugs · doi:10.1007/s40265-021-01611-0 · Cited by 467 · see citing works
Molecular Evolution of Antifungal Drug Resistance
Robbins, N., Caplan, T., & Cowen, L. E. (2017) · Annual Review of Microbiology · doi:10.1146/annurev-micro-030117-020345 · Cited by 441 · see citing works
Abad, A., Fernandez-Molina, J. V., Bikandi, J., Ramirez‐Garcia, A., Margareto, J., Sendino, J., Hernando, F. L., Pontón, J., Garaizar, J., & Rementerı́a, A. (2010) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2010.10.003 · Cited by 394 · see citing works
Fungal siderophore metabolism with a focus on <i>Aspergillus fumigatus</i>
Haas, H. (2014) · Nat. Prod. Rep. · doi:10.1039/c4np00071d · Cited by 324 · see citing works
Molecular mechanisms governing antifungal drug resistance
Lee, Y., Robbins, N., & Cowen, L. E. (2023) · npj Antimicrobials and Resistance · doi:10.1038/s44259-023-00007-2 · Cited by 304 · see citing works
Regulation of multidrug resistance in pathogenic fungi
Morschhäuser, J. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.08.002 · Cited by 300 · see citing works
Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium
Arastehfar, A. A., Gabaldón, T., Garcia‐Rubio, R., Jenks, J. D., Hoenigl, M., Salzer, H. J. F., İlkit, M., Lass‐Flörl, C., & Perlin, D. S. (2020) · Antibiotics · doi:10.3390/antibiotics9120877 · Cited by 294 · see citing works
Aspergillus fumigatus and Related SpeciesPreprint
Sugui, J. A., Kwon-Chung, K. J., Juvvadi, P. R., Latgé, J., & Steinbach, W. J. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019786 · Cited by 286 · see citing works
Che, P., Bussell, J. D., Zhou, W., Estavillo, G. M., Pogson, B. J., & Smith, S. M. (2010) · Science Signaling · doi:10.1126/scisignal.2001140 · Cited by 270 · see citing works
Azole-Resistant Aspergillosis: Epidemiology, Molecular Mechanisms, and Treatment
Chowdhary, A., Sharma, C., & Meis, J. F. G. M. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix210 · Cited by 264 · see citing works
Osborne, T. F., & Espenshade, P. J. (2009) · Genes & Development · doi:10.1101/gad.1854309 · Cited by 264 · see citing works
The Fungal CYP51s: Their Functions, Structures, Related Drug Resistance, and Inhibitors
Zhang, J., Li, L., Lv, Q., Yan, L., Wang, Y., & Jiang, Y. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00691 · Cited by 249 · see citing works
Aspergillus fumigatus and aspergillosis: From basics to clinics
Arastehfar, A. A., Carvalho, A., Houbraken, J. A. M. P., Lombardi, L., Garcia‐Rubio, R., Jenks, J. D., Rivero-Menéndez, O., Aljohani, R., Jacobsen, I. D., Berman, J. G., et al. (2021) · Studies in Mycology · doi:10.1016/j.simyco.2021.100115 · Cited by 250 · see citing works
Iron - a key nexus in the virulence of Aspergillus fumigatus
Haas, H. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00028 · Cited by 217 · see citing works
Grahl, N., Puttikamonkul, S., Macdonald, J. M., Gamcsik, M. P., Ngo, L. Y., Hohl, T. M., & Cramer, R. A. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002145 · Cited by 217 · see citing works
Self-citationCamps, S. M. T., Dutilh, B. E., Arendrup, M. C., Rijs, A. J. M. M., Snelders, E., Huynen, M. A., Verweij, P. E., & Melchers, W. J. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050034 · Cited by 208 · see citing works
Type III interferon is a critical regulator of innate antifungal immunity
Espinosa, V., Dutta, O., McElrath, C., Du, P., Chang, Y.-J., Cicciarelli, B., Pitler, A., Whitehead, I., Obar, J. J., Durbin, J. E., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aan5357 · Cited by 202 · see citing works
Chung, D., Barker, B. M., Carey, C. C., Merriman, B., Werner, E. R., Lechner, B. E., Dhingra, S., Cheng, C., Xu, W., Blosser, S. J., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004487 · Cited by 193 · see citing works
Self-citationIslam, T., Danishuddin, M., Tamanna, N. T., Matin, M. N., Barai, H. R., & Haque, M. A. (2024) · Plants · doi:10.3390/plants13192737 · Cited by 214 · see citing works
Alcázar‐Fuoli, L., & Mellado, E. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00439 · Cited by 187 · see citing works
Hypoxia and Fungal Pathogenesis: To Air or Not To Air?
Grahl, N., Shepardson, K. M., Chung, D., & Cramer, R. A. (2012) · Eukaryotic Cell · doi:10.1128/ec.00031-12 · Cited by 176 · see citing works
Self-citationEpidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus
Gonçalves, S. S., Souza, A. C. R., Chowdhary, A., Meis, J. F. G. M., & Colombo, A. L. (2016) · Mycoses · doi:10.1111/myc.12469 · Cited by 182 · see citing works
Aspergillus fumigatus: contours of an opportunistic human pathogen
McCormick, A., Loeffler, J., & Ebel, F. (2010) · Cellular Microbiology · doi:10.1111/j.1462-5822.2010.01517.x · Cited by 181 · see citing works
Blatzer, M., Barker, B. M., Willger, S. D., Beckmann, N., Blosser, S. J., Cornish, E. J., Mazurie, A., Grahl, N., Haas, H., & Cramer, R. A. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002374 · Cited by 175 · see citing works
Self-citationBien, C. M., & Espenshade, P. J. (2010) · Eukaryotic Cell · doi:10.1128/ec.00358-09 · Cited by 173 · see citing works
Fungal biofilm architecture produces hypoxic microenvironments that drive antifungal resistance
Kowalski, C. H., Morelli, K. A., Schultz, D., Nadell, C. D., & Cramer, R. A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003700117 · Cited by 149 · see citing works
Self-citationTriazole Resistance in Aspergillus Species: An Emerging Problem
Garcia‐Rubio, R., Cuenca‐Estrella, M., & Mellado, E. (2017) · Drugs · doi:10.1007/s40265-017-0714-4 · Cited by 155 · see citing works
Hagiwara, D., Miura, D., Shimizu, K., Paul, S., Ohba, A., Gonoi, T., Watanabe, A., Kamei, K., Shintani, T., Moye-Rowley, W. S., et al. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006096 · Cited by 156 · see citing works
Triazole resistance surveillance in Aspergillus fumigatus
Resendiz Sharpe, A., Lagrou, K., Meis, J. F., Chowdhary, A., Lockhart, S. R., Verweij, P. E., & on behalf of the ISHAM/ECMM Aspergillus Resistance Surveillance working group (2018) · Medical Mycology · doi:10.1093/mmy/myx144 · Cited by 150 · see citing works
Triazole Resistance in Aspergillus spp.: A Worldwide Problem?
Rivero-Menendez, O., Alastruey-Izquierdo, A., Mellado, E., & Cuenca-Estrella, M. (2016) · Journal of Fungi · doi:10.3390/jof2030021 · Cited by 142 · see citing works
Special relationship between sterols and oxygen: Were sterols an adaptation to aerobic life?
Galea, A. M., & Brown, A. J. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.06.027 · Cited by 141 · see citing works
The negative cofactor 2 complex is a key regulator of drug resistance in Aspergillus fumigatus
Furukawa, T., van Rhijn, N., Fraczek, M. G., Gsaller, F., Davies, E. A., Carr, P. D., Gago, S., Fortune‐Grant, R., Rahman, S., Gilsenan, J. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14191-1 · Cited by 133 · see citing works
Self-citationGenetic diversity and antifungal susceptibility profiles in causative agents of sporotrichosis
Rodrigues, A. M., de Hoog, S., Pires, D. D. C., Brihante, R. S. N., Sidrim, J. J. C., Gadelha, M. F. R., Colombo, A. L., & Camargo, Z. P. D. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-219 · Cited by 134 · see citing works
Gsaller, F., Hortschansky, P., Furukawa, T., Carr, P. D., Rash, B. M., Capilla, J., Müller, C., Bracher, F., Bowyer, P., Haas, H., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005775 · Cited by 134 · see citing works
Yin, W., Baccile, J. A., Bok, J. W., Chen, Y., Keller, N. P., & Schroeder, F. C. (2013) · Journal of the American Chemical Society · doi:10.1021/ja311145n · Cited by 133 · see citing works
Ben‐Ami, R., Lewis, R. E., & Kontoyiannis, D. P. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08283.x · Cited by 132 · see citing works
Regulation of the Hypoxic Response in Candida albicans
Synnott, J. M., Guida, A., Mulhern-Haughey, S., Higgins, D. G., & Butler, G. (2010) · Eukaryotic Cell · doi:10.1128/ec.00159-10 · Cited by 132 · see citing works
Chowdhary, A., Sharma, C., Hagen, F., & Meis, J. F. G. M. (2014) · Future Microbiology · doi:10.2217/fmb.14.27 · Cited by 132 · see citing works
Vödisch, M., Scherlach, K., Winkler, R., Hertweck, C., Braun, H.-P., Roth, M., Haas, H., Werner, E. R., Brakhage, A. A., & Kniemeyer, O. (2011) · Journal of Proteome Research · doi:10.1021/pr1012812 · Cited by 128 · see citing works
Barker, B. M., Kroll, K., Vödisch, M., Mazurie, A., Kniemeyer, O., & Cramer, R. A. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-62 · Cited by 127 · see citing works
Self-citationBarber, A. E., Sae-Ong, T., Kang, K., Seelbinder, B., Li, J., Walther, G., Panagiotou, G., & Kurzai, O. (2021) · Nature Microbiology · doi:10.1038/s41564-021-00993-x · Cited by 127 · see citing works
Yasmin, S., Alcazar-Fuoli, L., Gründlinger, M., Puempel, T., Cairns, T., Blatzer, M., Lopez, J. F., Grimalt, J. O., Bignell, E., & Haas, H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106399108 · Cited by 126 · see citing works
Kowalski, C. H., Beattie, S. R., Fuller, K. K., McGurk, E. A., Tang, Y.-W., Hohl, T. M., Obar, J. J., & Cramer, R. A. (2016) · mBio · doi:10.1128/mbio.01515-16 · Cited by 123 · see citing works
Self-citationPuttikamonkul, S., Willger, S. D., Grahl, N., Perfect, J. R., Movahed, N., Bothner, B. B., Park, S., Paderu, P., Perlin, D. S., & Cramer, R. A. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2010.07254.x · Cited by 119 · see citing works
Self-citationDhingra, S., & Cramer, R. A. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00092 · Cited by 114 · see citing works
Self-citationGenetic Engineering of Filamentous Fungi for Efficient Protein Expression and Secretion
Wang, Q., Zhong, C., & Xiao, H. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00293 · Cited by 116 · see citing works
Feng, X., Krishnan, K., Richie, D. L., Aimanianda, V., Hartl, L., Grahl, N., Powers-Fletcher, M. V., Zhang, M., Fuller, K. K., Nierman, W. C., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002330 · Cited by 112 · see citing works
Self-citationPathogenicity and virulence of Aspergillus fumigatus
Earle, K., Valero, C., Conn, D. P., Vere, G., Cook, P. C., Bromley, M., Bowyer, P., & Gago, S. (2023) · Virulence · doi:10.1080/21505594.2023.2172264 · Cited by 117 · see citing works
Beattie, S. R., Mark, K. M. K., Thammahong, A., Ries, L. N. A., Dhingra, S., Caffrey-Carr, A. K., Cheng, C., Black, C. C., Bowyer, P., Bromley, M. J., et al. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006340 · Cited by 103 · see citing works
Self-citationFungal biofilm morphology impacts hypoxia fitness and disease progression
Kowalski, C. H., Kerkaert, J. D., Liu, K.-W., Bond, M. C., Hartmann, R., Nadell, C. D., Stajich, J., & Cramer, R. A. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0558-7 · Cited by 103 · see citing works
Self-citationImmune responses against Aspergillus fumigatus
Cramer, R. A., Rivera, A., & Hohl, T. M. (2011) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e328348b159 · Cited by 99 · see citing works
Self-citationGrahl, N., Dinamarco, T. M., Willger, S. D., Goldman, G. H., & Cramer, R. A. (2012) · Molecular Microbiology · doi:10.1111/j.1365-2958.2012.08034.x · Cited by 99 · see citing works
Self-citationLipid Biosynthesis as an Antifungal Target
Pan, J., Hu, C., & Yu, J. (2018) · Journal of Fungi · doi:10.3390/jof4020050 · Cited by 99 · see citing works
Morelli, K. A., Kerkaert, J. D., & Cramer, R. A. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009794 · Cited by 98 · see citing works
Self-citationSnelders, E., Melchers, W. J. G., & Verweij, P. E. (2011) · Future Microbiology · doi:10.2217/fmb.11.4 · Cited by 96 · see citing works
Aspergillus fumigatus and pan-azole resistance: who should be concerned?
Wiederhold, N. P., & Verweij, P. E. (2020) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000662 · Cited by 93 · see citing works
Recent advances in the genome mining of Aspergillus secondary metabolites (covering 2012–2018)
Romsdahl, J., & Wang, C. C. C. (2019) · MedChemComm · doi:10.1039/c9md00054b · Cited by 92 · see citing works
AtrR Is an Essential Determinant of Azole Resistance in Aspergillus fumigatus
Paul, S., Stamnes, M., Thomas, G. H., Liu, H., Hagiwara, D., Gomi, K., Filler, S. G., & Moye-Rowley, W. S. (2019) · mBio · doi:10.1128/mbio.02563-18 · Cited by 91 · see citing works
Tøndervik, A., Sletta, H., Klinkenberg, G., Emanuel, C., Powell, L. C., Pritchard, M., Khan, S. S., Craine, K. M., Onsøyen, E., Rye, P. D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112518 · Cited by 91 · see citing works
Hagiwara, D., Sakamoto, K., Abe, K., & Gomi, K. (2016) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2016.1162085 · Cited by 87 · see citing works
Lü, Y., Su, C., Solis, N. V., Filler, S. G., & Liu, H. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.10.008 · Cited by 87 · see citing works
On the lineage of Aspergillus fumigatus isolates in common laboratory use
Bertuzzi, M., van Rhijn, N., Krappmann, S., Bowyer, P., Bromley, M., & Bignell, E. (2020) · Medical Mycology · doi:10.1093/mmy/myaa075 · Cited by 85 · see citing works
Novodvorska, M., Stratford, M., Blythe, M. J., Wilson, R., Beniston, R. G., & Archer, D. B. (2016) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2016.07.002 · Cited by 79 · see citing works
Shepardson, K. M., Jhingran, A., Caffrey, A., Obar, J. J., Suratt, B. T., Berwin, B. L., Hohl, T. M., & Cramer, R. A. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004378 · Cited by 79 · see citing works
Self-citationBlosser, S. J., & Cramer, R. A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05027-11 · Cited by 79 · see citing works
Self-citationHypoxia, innate immunity and infection in the lung
Schaible, B., Schaffer, K., & Taylor, C. T. (2010) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2010.08.006 · Cited by 77 · see citing works
The contribution of Aspergillus fumigatus stress responses to virulence and antifungal resistance
Brown, N. A., & Goldman, G. H. (2016) · The Journal of Microbiology · doi:10.1007/s12275-016-5510-4 · Cited by 77 · see citing works
Liu, S., Mauff, F. L., Sheppard, D. C., & Zhang, S. (2022) · npj Biofilms and Microbiomes · doi:10.1038/s41522-022-00347-3 · Cited by 73 · see citing works
Hypoxia enhances innate immune activation to Aspergillus fumigatus through cell wall modulation
Shepardson, K. M., Ngo, L. Y., Aimanianda, V., Latgé, J., Barker, B. M., Blosser, S. J., Iwakura, Y., Hohl, T. M., & Cramer, R. A. (2012) · Microbes and Infection · doi:10.1016/j.micinf.2012.11.010 · Cited by 75 · see citing works
Self-citationSystems Biology of Fungal Infection
Horn, F., Heinekamp, T., Kniemeyer, O., Pollmächer, J., Valiante, V., & Brakhage, A. A. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00108 · Cited by 72 · see citing works
Maguire, S. L., Wang, C., Holland, L. M., Brunel, F., Neuvéglise, C., Nicaud, J.-M., Zavrel, M., White, T. C., Wolfe, K. H., & Butler, G. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004076 · Cited by 69 · see citing works
Song, J., Zhang, S., & Lü, L. (2018) · Fungal Biology Reviews · doi:10.1016/j.fbr.2018.05.001 · Cited by 68 · see citing works
Azole-Resistant Invasive Aspergillosis: Relationship to Agriculture
Stensvold, C. R., Jørgensen, L. N., & Arendrup, M. C. (2012) · Current Fungal Infection Reports · doi:10.1007/s12281-012-0097-7 · Cited by 67 · see citing works
Willger, S. D., Cornish, E. J., Chung, D., Fleming, B. A., Lehmann, M. M., Puttikamonkul, S., & Cramer, R. A. (2012) · Eukaryotic Cell · doi:10.1128/ec.00252-12 · Cited by 67 · see citing works
Self-citationBaldin, C., Valiante, V., Krüger, T., Schafferer, L., Haas, H., Kniemeyer, O., & Brakhage, A. A. (2015) · PROTEOMICS · doi:10.1002/pmic.201400584 · Cited by 64 · see citing works
Lind, A. L., Lim, F. Y., Soukup, A. A., Keller, N. P., & Rokas, A. (2018) · mSphere · doi:10.1128/msphere.00050-18 · Cited by 64 · see citing works
Francesco, M. A. D. (2023) · Pathogens · doi:10.3390/pathogens12111305 · Cited by 65 · see citing works
Valiante, V., Baldin, C., Hortschansky, P., Jain, R., Thywißen, A., Straßburger, M., Shelest, E., Heinekamp, T., & Brakhage, A. A. (2016) · Molecular Microbiology · doi:10.1111/mmi.13462 · Cited by 63 · see citing works
Neutrophil Interactions Stimulate Evasive Hyphal Branching by Aspergillus fumigatus
Ellett, F. E., Jorgensen, J. A., Frydman, G. H., Jones, C. N., & Irimia, D. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006154 · Cited by 62 · see citing works
Aspergillus fumigatus AcuM regulates both iron acquisition and gluconeogenesis: A. fumigatus AcuM
Liu, H., Gravelat, F. N., Chiang, L. Y., Chen, D., Vanier, G., Ejzykowicz, D. E., Ibrahim, A. S., Nierman, W. C., Sheppard, D. C., & Filler, S. G. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2010.07389.x · Cited by 61 · see citing works
Bien, C. M., Chang, Y. C., Nes, W. D., Kwon-Chung, K. J., & Espenshade, P. J. (2009) · Molecular Microbiology · doi:10.1111/j.1365-2958.2009.06895.x · Cited by 62 · see citing works
Insights into the cellular responses to hypoxia in filamentous fungi
Hillmann, F., Shekhova, E., & Kniemeyer, O. (2015) · Current Genetics · doi:10.1007/s00294-015-0487-9 · Cited by 59 · see citing works
Regulation of hypoxia adaptation: an overlooked virulence attribute of pathogenic fungi?
Grahl, N., & Cramer, R. A. (2009) · Medical Mycology · doi:10.3109/13693780902947342 · Cited by 59 · see citing works
Self-citationThe Immune Interplay between the Host and the Pathogen inAspergillus fumigatusLung Infection
Sales‐Campos, H., Tonani, L., Cardoso, C. R. D. B., & Kress, M. R. V. Z. (2013) · BioMed Research International · doi:10.1155/2013/693023 · Cited by 58 · see citing works
Franken, A. C. W., Lokman, B. C., Ram, A. F. J., Punt, P. J., van den Hondel, C. A. M. J. J., & de Weert, S. (2011) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3391-3 · Cited by 56 · see citing works
Mead, M. E., Knowles, S. L., Raja, H. A., Beattie, S. R., Kowalski, C. H., Steenwyk, J. L., Silva, L. P., Chiaratto, J., Ries, L. N. A., Goldman, G. H., et al. (2019) · mSphere · doi:10.1128/msphere.00018-19 · Cited by 53 · see citing works
Self-citationAspergillus fumigatus Photobiology Illuminates the Marked Heterogeneity between Isolates
Fuller, K. K., Cramer, R. A., Zegans, M. E., Dunlap, J. C., & Loros, J. J. (2016) · mBio · doi:10.1128/mbio.01517-16 · Cited by 55 · see citing works
Self-citationA secondary mechanism of action for triazole antifungals in Aspergillus fumigatus mediated by hmg1
Rybak, J. M., Xie, J., Martín‐Vicente, A., Guruceaga, X., Thorn, H. I., Nywening, A. V., Ge, W., Souza, A. C. O., Shetty, A. C., McCracken, C. L., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48029-2 · Cited by 55 · see citing works
Aspergillus fumigatus biology, immunopathogenicity and drug resistance
van de Veerdonk, F. L., Carvalho, A., Wauters, J., Chamilos, G., & Verweij, P. E. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01180-z · Cited by 58 · see citing works
Li, H., Barker, B. M., Grahl, N., Puttikamonkul, S., Bell, J. D., Craven, K. D., & Cramer, R. A. (2010) · Eukaryotic Cell · doi:10.1128/ec.00288-10 · Cited by 55 · see citing works
Self-citationProtein kinase A and fungal virulence
Fuller, K. K., & Rhodes, J. C. (2012) · Virulence · doi:10.4161/viru.19396 · Cited by 53 · see citing works
Fuller, K. K., Richie, D. L., Feng, X., Krishnan, K., Stephens, T., Wikenheiser‐Brokamp, K. A., Askew, D. S., & Rhodes, J. C. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2010.07509.x · Cited by 53 · see citing works
Shaping the fungal adaptome – Stress responses of Aspergillus fumigatus
Hartmann, T., Sasse, C., Schedler, A., Hasenberg, M., Gunzer, M., & Krappmann, S. (2011) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2011.04.008 · Cited by 52 · see citing works
Elucidating the fungal stress response by proteomics
Kroll, K. L., Pähtz, V., & Kniemeyer, O. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.06.001 · Cited by 52 · see citing works
Molecular bases of antifungal resistance in filamentous fungi
Sharma, C., & Chowdhary, A. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.06.018 · Cited by 51 · see citing works
- Authors
- Willger, S. D., Puttikamonkul, S., Kim, K.-H., Burritt, J. B., Grahl, N., Metzler, L. J., Barbuch, R., Bard, M., Lawrence, C. B., & Cramer, R. A.
- Affiliations
- Montana State University (US)
- Virginia Tech (US)
- Indiana University – Purdue University Indianapolis (US)
- Corresponding author
- Cramer, Robert A.
- ORCID
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-11-07
- Volume
- 4
- Issue
- 11
- Pages
- e1000200
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC2572145
- OpenAlex
- W1973084729
- Semantic Scholar
- 802ec4d21922ca7d880b430703b49d264f0f8e35
- Cited by
- 345
- References
- 84
- Citations by year
- 2026: 18 · 2025: 15 · 2024: 17 · 2023: 14 · 2022: 15 · 2021: 27 · 2020: 23 · 2019: 23 · 2018: 17 · 2017: 31 · 2016: 28 · 2015: 15 · 2014: 19 · 2013: 22 · 2012: 22
- FWCI
- 5.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- IUScholarWorks (Indiana University) (submittedVersion, cc-by)
- VTechWorks (Virginia Tech) (submittedVersion)
- Publisher
- Funders
- Montana State University
- National Institutes of Health (RR 020185)
- National Institute of General Medical Sciences (R01GM062104, GM 62104)
- National Institute of Allergy and Infectious Diseases (L40 AI084526)
- National Center for Research Resources (P20RR020185, RR 020185)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
- Keywords
- Aspergillus fumigatus, SREBP, hypoxia adaptation, cell polarity, fluconazole, voriconazole, ergosterol biosynthesis, sterol biosynthesis, hyphal morphology, invasive pulmonary aspergillosis, fungal virulence, gene expression profiling, filamentous fungi
- MeSH terms
- Adaptation, Physiological, Animals, Hypoxia, Aspergillus fumigatus, Azoles, Drug Resistance, Fungal Proteins, Mice, Inbred Strains, Transcription, Genetic, Virulence, Gene Expression Regulation, Fungal, Cell Polarity, Gene Expression Profiling, Mice, Sterol Regulatory Element Binding Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review